SlideShare uma empresa Scribd logo
1 de 29
Baixar para ler offline
Opening up clinical performance
variation and financial incentives in Primary Care quality of care
Evan (Evangelos) Kontopantelis1
1Institute of Population Health
Faculty Research Series, 25 September 2013
Kontopantelis (IPH) Variation and financial incentives 25 September 2013
Outline
1 People
2 The scheme...
3 The research journey
4 Summary
Kontopantelis (IPH) Variation and financial incentives 25 September 2013
Collaborative work!
Martin Roland
Tim Doran
David Reeves
Stephen Campbell
Bonnie Sibbald
Matt Sutton
Hugh Gravelle
Jose Valderas
...and others...
Kontopantelis (IPH) Variation and financial incentives 25 September 2013
Improving quality of care
a (very) juicy carrot...
A pay-for-performance (p4p) program kicked off in April 2004 with
the introduction of a new GP contract
General practices are rewarded for achieving a set of quality targets
for patients with chronic conditions
The aim was to increase overall quality of care and to reduce
variation in quality between practices
The incentive scheme for payment of GPs was named the Quality
and Outcomes Framework (QOF)
Initial investment estimated at £1.8 bn for 3 years (increasing GP
income by up to 25%)
QOF is reviewed at least every two years
Kontopantelis (IPH) Variation and financial incentives 25 September 2013
Quality and Outcomes Framework
details for years 1 (2004/5) and 7 (2010/11)
Domains and indicators in year 1 (year 7):
Clinical care for 10 (19) chronic diseases, with 76 (80) indicators
Organisation of care, with 56 (36) indicators
Additional services, with 10 (8) indicators
Patient experience, with 4 (5) indicators
Implemented simultaneously in all practices (a control group was
out of the question)
Practices are allowed to exclude patients from the indicators and
the payment calculations
Into the 10th year now (01Mar13/31Apr14); cost for the first 9
years was well above the estimate at £9 bn approximately
Kontopantelis (IPH) Variation and financial incentives 25 September 2013
Quality and Outcomes Framework
what does it mean?
If you have
Atrial fibrillation, asthma, HT, cancer, CHD,
HF, CKD, COPD, dementia, depression,
diabetes, epilepsy, SMI, osteoporosis, PAD,
stroke, hypothyroidism
but also covers LD, obesity, palliative care,
sexual health, smoking
e.g. for diabetes
measure-control BP, chol, glucose
immunise for influenza
physical exams (retinal screen, foot exam)
...and more... 17 indicators in total
Kontopantelis (IPH) Variation and financial incentives 25 September 2013
Quality and Outcomes Framework
2005 reaction
Drugs cut strokes by a third
Doctors get 20%
pay rise just for
doing their jobsDOCTORS are getting 20 per
cent pay rises for doing simple
tasks “they should always have
done,” it was claimed last night.
Health economists, including
Government advisers, say that
under their new contracts GPs
are being paid huge bonuses to
meet “easy” targets that do little
to improve patients’ lives.
Such is the level of concern
over the value for taxpayers that
ministers are already meeting
doctors’ leaders in order to set
tougher goals.
The move comes just weeks
after the Government boasted
how most GPs had met the tar-
gets for performance-related pay.
But Alan Maynard, professor of
health economics at York Univer-
sity, said yesterday: “It’s quite
ridiculous. The Government’s
CHOLESTEROL -lowering
drugs called statins could pre-
vent heart attacks and strokes in
a third of patients with diseased
arteries, a study shows.
Most doctors consider statin
treatment only when blood cho-
lesterol is above a certain level
but research by British and
Australian scientists shows
many more people with lower
cholesterol could also benefit.
Statins work by blocking the
action of an enzyme that enables
the liver to produce cholesterol.
Research Council scientist Dr
Colin Baigent, who coordinated
By Michael Day
By Geoff Marsh
spent all this money and has
given GPs 20 per cent rises just to
try and get them to do what they
should always have done.
“Now they’re being paid extra
to look out for people with high
blood pressure, which causes
heart attacks and strokes, and to
monitor and treat them – but they
should have been doing that all
along. It’s not rocket science.”
There have already been two
Whitehall meetings after the dis-
closure last month that, on aver-
age, GP practices achieved 91 per
cent of the available perfor-
mance-related bonuses under the
new contract.
After achieving bonuses, aver-
age earnings of a practice surged
by £75,000 while the salary of the
average GP partner rose to
£100,000 a year. The first meeting
to set tougher targets came with-
in a week of the announcement.
The second was held last week.
One BMA negotiator, Leeds GP
Richard Vautrey, said: “We are
looking at making amendments,
but at present we’re not in
the position to say exactly what
these are.
“We would expect the revised
framework to be ready by the end
of the year.”
Apart from blood pressure,
other target areas have been sin-
gled out as too modest. Chris
Ham, professor of health policy
and management at Birmingham
University, said: “My view is that,
in principle, the new GP contract
is a good thing – GPs are being
paid on the basis of how well they
treat patients and not just accord-
ing to how large their list size is.
“But the fact so many of them
met the targets in the first year
suggests they were too easy.”
A BMA spokeswoman denied
the targets were too easy. “They
demonstrate the vast majority of
doctors are already providing
high-quality care for their
patients,” she said.
Simon William, director of pol-
icy at the Patients’ Association,
said, however: “The BMA would
trumpet the GPs’ performance.
It’s a trade union, it’s there to
represent doctors not patients.”
A spokesman for the Depart-
ment of Health said: “These
excellent results show the new
contract is giving GPs a real
incentive to improve the quality
of care.”
the research at Oxford Univer-
sity, said: “This study shows
statin drugs could be beneficial
in a much wider range of
patients than is currently con-
sidered for treatment.
“What matters most is doc-
tors identify all patients at risk
of a heart attack or stroke –
largely ignoring their present
blood cholesterol level – and
then prescribe a statin at a daily
dose that reduces their choles-
terol substantially.
“Lowering the bad (LDL) cho-
lesterol … with a statin should
reduce the risk of a heart attack
or stroke by at least one third.”
The study, published online in
The Lancet, suggests patients
given a statin would also experi-
ence greater benefits if doctors
aimed to achieve larger reduc-
tions in cholesterol levels.
The analysis also provides
information about the safety of
statins. Earlier studies had
raised concerns they could be
linked with an increased risk of
certain cancers or diseases.
British Heart Foundation
Professor Rory Collins, one of
the study authors, said: “This
work shows clearly that statins
are very safe. There is no good
evidence that statins cause can-
cer and nor do they increase the
risk of other diseases. Although
statins can cause muscle pain or
weakness, our study shows seri-
ous cases are extremely rare.”
Study co-author Professor
John Simes, of Sydney Univer-
sity, said: “The benefits of statin
treatment were seen in all pat-
ient groups, including women,
the elderly, individuals with dia-
betes and those with and with-
out prior heart attack or stroke.”
OPINION 12 DIARY 26 LETTERS 38 TV 39 STARS 43 CROSSWORDS 45 CITY 48 SPORT 52
If you have a story:
Ring 0871 520 2982
If you have a photo:
Ring 0871 520 7171
or send mobile phone pictures
by texting EXPRESS to
07843 500 911
or email to:
expresspix@express.co.uk
DO YOU
HAVE A
STORY
OR A
PHOTO?
We asked in our poll
on Saturday: Should Blair
resign over sending
troops to Iraq?
Yes:97% No: 3%
RESULTS OF
PHONE POLL
3 6 5
8 9 3 4
9 4 5 3 6
9 5 7 1 6
1 5
3 9 5 8 7
7 5 1 4 3
5 2 9 8
1 8 6
Fill in all the squares so that each row, each column,
and 3x3 square contain all the digits from 1 to 9.SUDOKU
7 8 6 1 9 3 5 2 4
2 1 9 5 7 4 8 6 3
5 3 4 8 2 6 9 7 1
4 9 7 2 1 5 6 3 8
8 2 5 6 3 7 1 4 9
3 6 1 9 4 8 7 5 2
9 7 2 3 5 1 4 8 6
6 4 3 7 8 9 2 1 5
1 5 8 4 6 2 3 9 7
Yesterday’s solution
This is the Quick Sudoku
for the solver in a hurry.
For today’s solution call:
0905 072 0051
For extra clues call:
0905 072 0052
(calls cost 75p per minute
from a BT landline)
Another Sudoku: PAGE 45
● The Daily Express Sudoku Book is available from October 3 at £5.99 (p&p included for UK). Don’t miss out,
pre-order your copy now! Send cheque or postal order to Express Bookshop, PO Box 200, Falmouth, Cornwall
TR11 4WJ or call 0871 434 6091, or you can order on-line at www.expressbookshop.com
LOTTO NUMBERS
WEDNESDAY LOTTO
September 21
2 23 33 35 40 42 25
Estimated jackpot is £2.8m
Extra: 2 13 18 25 28 47
Estimated jackpot is £8.7m
T-Ball: 5 14 16 18 32 2
DAILY PLAY
Saturday
1 7 8 12 21 23 24
SATURDAY LOTTO
Sept 24
2 11 27 29 36 44 15
Estimated jackpot is £8.4m
Extra: 3 11 16 34 40 45
Jackpot is £9m this week
T-Ball: 6 8 20 26 34 5
EUROMILLIONS
September 23
1 26 31 34 47
Lucky star numbers: 4 9
Amsterdam . . .c 17 63
Athens . . . . . . .f 25 77
Berlin . . . . . . . .sh 16 61
Cape Town . . . .s 16 61
Corfu . . . . . . . .f 25 77
Dublin . . . . . . .c 18 64
Faro . . . . . . . . .s 24 75
Geneva . . . . . .f 20 68
Gibraltar . . . . . .f 23 73
Guernsey . . . . .s 17 63
Los Angeles . . .f 21 70
Madrid . . . . . . .s 22 72
Malaga . . . . . . .f 24 75
Mallorca . . . . . .s 24 75
Malta . . . . . . . .s 25 77
Miami . . . . . . . .f 31 88
Moscow . . . . . .c 14 57
New York . . . . .c 22 72
Nice . . . . . . . . .s 24 75
Paris . . . . . . . . .c 20 68
Rome . . . . . . . .s 23 73
Stockholm . . . .s 20 68
Sydney . . . . . .r 19 66
Tel Aviv . . . . . . .s 34 93
Tenerife . . . . . .s 28 82
Summary: Showers in places.
World yesterday
Europe today
C F A windy day with rain spreading
eastwards across most areas,
but the south and east of England
will have a fine start.
Outlook tomorrow:
North West East Anglia
Breezy with scattered
showers, locally heavy.
A fresh south-westerly wind.
High 18C (64F).
Early rain will clear to leave
sunny spells. A risk of showers
later. Moderate south-westerly
winds. High 20C (68F).
Northern Ireland London/South East
Sunny intervals and
showers. Cool and breezy
with a strong south-westerly
breeze. High 16C (61F).
After a cloudy start with
rain in places, it will soon
become drier with spells
of sunshine. High 21C (70F).
Wales South
Some sunshine at times,
but with scattered showers,
frequent in the west. Fresh
winds. High 18C (64F).
A cloudy start in places,
but turning brighter with
sunny spells. Afternoon
showers. High 20C (68F).
Midlands South West
Sunny spells, but with a
few showers from the west.
Moderate south-westerly
winds. High 20C (68F).
Some sunshine at times,
but with occasional showers.
Moderate westerly winds.
High 19C (66F).
North East/Yorks Channel Isles
A bright day with sunny spells,
but breezy with the chance
of a shower A fresh breeze.
High 18C (64F).
Early rain will soon clear
to leave sunny intervals,
but with a risk of a shower.
High 18C (64F).
Scotland Sea
Gusty at times with frequent,
heavy showers in the west.
Drier and brighter further
east. High 18C (64F).
North Sea: moderate.
Irish Sea: moderate.
Channel: moderate.
Rain 19C/66F
Amsterdam
Fair 19C/66F
Brussels
Fair 22C/72F
Frankfurt
Fair 23C/73F
Geneva
Fair 22C/72F
Paris
Fair 25C/77F
Rome
Warmest: Chivenor 19C (66F).
Coldest: Aboyne 2C (36F).
Wettest: S’th Uist Range 0.55in.
Sunniest: Beccles 5.0hr.
BRITAIN EXTREMES:
(24 hours to 2pm yesterday)
c-cloudy, dr-drizzle, f-fair, fg-fog,
g-gales, h-hail, hz-haze, m-mist,
r-rain, sh-showers, s-sun,
sn-snow, sl-sleet, th-thunder,
Around Britain
HIGH TIDE: London Bridge: 9.03am, 10.00pm
Liverpool: 7.14am, 7.53pm
Greenock: 8.31am, 7.42pm
Dover: 7.04am, 8.01pm
Belfast 0.0 0.13 9 17
Birmingham 2.0 0.00 9 17
Bristol 2.3 0.00 10 19
Cardiff 3.0 0.01 11 20
Edinburgh 2.0 0.04 7 18
Glasgow 0.9 0.94 10 15
Leeds ** ** 9 16
London 3.4 0.00 12 18
Manchester 1.1 0.00 8 17
Newcastle ** 0.00 10 17
Norwich 3.7 0.04 7 16
Oxford 1.5 0.00 7 17
CITIES
Sun Rain Temp
(hr) (in) (min)(max)
Lighting-up times Yesterday
Belfast 7.10pm-7.20am
Birmingham 6.54pm-7.03am
Bristol 6.57pm-7.06am
Glasgow 7.03pm-7.14am
London 6.47pm-6.56am
Manchester 6.55pm-7.05am
Newcastle 6.52pm-7.03am
MOON rises: –, Sets: 5.14pm
SUN rises London: 6.55am, Sets: 6.47pm
Manchester rises: 7.03am, Sets: 6.55pm
Moon, sun and tides
25
30
30
20
15
13
13
16
18
18
18
19
17
1818
20
20
20
21
Weather today
Miami 31C 88F / Moscow 14C 57F
All forecasts and maps provided by PA WeatherCentre
Daily Express Tuesday September 27 20052
Kontopantelis (IPH) Variation and financial incentives 25 September 2013
Quality and Outcomes Framework
later reaction
Kontopantelis (IPH) Variation and financial incentives 25 September 2013
Key questions
since QOF was parachuted in Primary Care
What were levels of achievement when QOF introduced?
Did they change over time?
What was happening pre-QOF? Was there an increasing trend?
Practice characteristics asssociated with high performance? Size?
Gap between practices in affluent and deprived areas?
Exception reporting rates and evidence for practice ‘gaming’?
What happened to non-incentivised aspects of care?
Did the intervention effect vary by population group?
What about patient satisfaction?
Various computer systems used. Does system choice affect care?
Kontopantelis (IPH) Variation and financial incentives 25 September 2013
Timeline
1998 2014
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013
2003
QuIP tp #2
2005
QuIP tp #3
2009
GP Patient
Satisfaction Survey
01/04/2004
QOF introduced
1998 - 2007
QuIP
1998
QuIP time point #1
2005
QOF y1*
2008
GPRD (CPRD)
access
2007
QuIP tp #4
2013
QOF y9
2004 - 2014
QMAS
Kontopantelis (IPH) Variation and financial incentives 25 September 2013
Timeline
1998 2014
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013
2003
QuIP tp #2
2005
QuIP tp #3
2009
GP Patient
Satisfaction Survey
01/04/2004
QOF introduced
2005
Where's the sun?
1998 - 2007
QuIP
1998
QuIP time point #1
2005
QOF y1*
2008
GPRD (CPRD)
access
2007
QuIP tp #4
2013
QOF y9
2004 - 2014
QMAS
Kontopantelis (IPH) Variation and financial incentives 25 September 2013
Levels of achievement in the first year (2004-5)
All 8000+ English practices
Median reported achievement
was 83.4% (IQR: 78.2-87.0%)
Very high achievement levels
Small effects of
sociodemographic
characteristics
Exception reporting not
extensive but the strongest
predictor
A few practices scored high by
excluding large numbers of
patients
The new engl and jour nal of medicine
n engl j med 355;4 www.nejm.org july 27, 2006 375
special article
Pay-for-Performance Programs in Family
Practices in the United Kingdom
Tim Doran, M.P.H., Catherine Fullwood, Ph.D., Hugh Gravelle, Ph.D.,
David Reeves, Ph.D., Evangelos Kontopantelis, Ph.D., Urara Hiroeh, Ph.D.,
and Martin Roland, D.M.
From the National Primary Care Research
and Development Centre, University of
Manchester, Manchester, United King-
dom. Address reprint requests to Dr.
Doran at the National Primary Care Re-
search and Development Centre, William-
son Bldg., University of Manchester, Man-
chester M13 9PL, United Kingdom, or at
tim.doran@manchester.ac.uk.
N Engl J Med 2006;355:375-84.
Copyright © 2006 Massachusetts Medical Society.
Abstr act
Background
In 2004, after a series of national initiatives associated with marked improvements
in the quality of care, the National Health Service of the United Kingdom introduced
a pay-for-performance contract for family practitioners. This contract increases exist-
ing income according to performance with respect to 146 quality indicators cover-
ing clinical care for 10 chronic diseases, organization of care, and patient experience.
Methods
We analyzed data extracted automatically from clinical computing systems for 8105
family practices in England in the first year of the pay-for-performance program
(April 2004 through March 2005), data from the U.K. Census, and data on charac-
teristics of individual family practices. We examined the proportion of patients deemed
eligible for a clinical quality indicator for whom the indicator was met (reported
achievement) and the proportion of the total number of patients with a medical con-
dition for whom a quality indicator was met (population achievement), and we used
multiple regression analysis to determine the extent to which practices achieved high
scores by classifying patients as ineligible for quality indicators (exception reporting).
Results
The median reported achievement in the first year of the new contract was 83.4 per-
cent (interquartile range, 78.2 to 87.0 percent). Sociodemographic characteristics of
the patients (age and socioeconomic features) and practices (size of practice, num-
ber of patients per practitioner, age of practitioner, and whether the practitioner was
medically educated in the United Kingdom) had moderate but significant effects on
performance. Exception reporting by practices was not extensive (median rate, 6 per-
cent), but it was the strongest predictor of achievement: a 1 percent increase in the
rate of exception reporting was associated with a 0.31 percent increase in reported
achievement. Exception reporting was high in a small number of practices: 1 percent
of practices excluded more than 15 percent of patients.
Conclusions
English family practices attained high levels of achievement in the first year of the
new pay-for-performance contract. A small number of practices appear to have
achieved high scores by excluding large numbers of patients by exception reporting.
More research is needed to determine whether these practices are excluding pa-
tients for sound clinical reasons or in order to increase income.
Kontopantelis (IPH) Variation and financial incentives 25 September 2013
Trends of prior achievement and 2004-5 expectations
Representative sample of 42 practices
Quality of care for CHD,
asthma and diabetes improved
between 2003 and 2005,
continuing the earlier trend
Increase in rate of
improvement significant only
for asthma and diabetes
Better recording or care?
Practices were preparing in
2003, in anticipation of the
scheme launch?
Gains from the scheme
become questionable, from a
cost-effectiveness perspective
n engl j med 357;2  www.nejm.o182
center Manchester National Health Service.
Data Collection
Trained research staff extracted the data to assess
the quality of clinical care for the categories of
coronary heart disease (15 clinical indicators),
asthma (12 clinical indicators), and type 2 dia-
betes (21 clinical indicators). Data were collected
from both computerized and handwritten medi-
tients
pract
have
for up
practi
for a
tients
These
acros
Alt
that w
in the
clinic
asthm
incen
pared
were
cial in
we ex
this d
clear
vided
Statis
An ov
puted
and 2
heart
comp
cators
divide
that p
repre
provid
100. W
our p
for th
90
MeanPractice-QualityScore(%)
80
85
70
60
55
75
65
0
1998 1999 2000 2001 2002 2003 2004 2005
CHD
Asthma
Diabetes
Year
AUTHOR:
FIGURE:
JOB:
4-C
H/T
RETAKE
SIZE
ICM
CASE
EMail Line
H/T
Combo
Revised
AUTHOR, PLEASE NOTE:
Figure has been redrawn and type has been reset.
Please check carefully.
REG F
Enon
1st
2nd
3rd
Campbell
1 of 1
07-12-07
ARTIST: ts
35702 ISSUE:
22p3
Figure 1. Mean Scores for Clinical Quality at the Practice Level for Coronary
Heart Disease, Asthma, and Type 2 Diabetes, 1998 to 2005.
The quality of care for coronary heart disease (CHD), asthma, and type 2
diabetes was improving between 1998 and 2003, before the introduction of
pay for performance. The rate of improvement in quality of care increased
significantly for diabetes and asthma between 2003 and 2005, after the in-
troduction of pay for performance; the rate for coronary heart disease,
which was increasing most rapidly before pay for performance, continued
at the same rate after pay for performance was introduced.
The New England Journal of Med
Downloaded from nejm.org at UNIV OF MANCHESTER JOHN RYLANDS LIB on September
Copyright © 2007 Massachusetts Medical Society
spe ci a l r ep or t
The new engl and jour nal of medicine
Quality of Primary Care in England
with the Introduction of Pay for Performance
Stephen Campbell, Ph.D., David Reeves, Ph.D., Evangelos Kontopantelis, Ph.D.,
Elizabeth Middleton, M.Sc., Bonnie Sibbald, Ph.D., and Martin Roland, D.M.
In 2004, the United Kingdom committed £1.8 bil-
lion ($3.2 billion) to a new pay-for-performance
contract for family practitioners.1 During the first
year, the levels of achievement exceeded those an-
ticipated by the government, with an average of
83.4% of the available incentive payments claimed.2
However, the quality of care in English family
practices had already begun to improve in response
to a wide range of initiatives,3-6 including nation-
al standards for the treatment of major chronic
diseases and a national system of inspection (Ta-
before the pay-for-performance program was in-
troduced and at one time point (2005) after its
introduction. A validated set of criteria was used
to assess quality in the management of three
chronic conditions: asthma, coronary heart dis-
ease, and type 2 diabetes. Because some clinical
indicators — the measures of the quality of clini-
cal care — were not rewarded with financial pay-
ments in the 2004 pay-for-performance program,
the study design also permitted a comparison of
trends in the quality of care for indicators forKontopantelis (IPH) Variation and financial incentives 25 September 2013
Performance over time and its variation
All 8000+ English practices
Median overall
achievement was 85.1%,
89.3% and 90.8% in first 3y
Median achievement
increased by 4.4% for
quintile of most affluent and
by 7.6% for most deprived
Gap in median
achievement narrowed from
4.0% to 0.8%
Financial incentive
schemes can contribute to
the reduction of inequalities
Information about practice and patient characteristics
was taken from the 2006 general medical statistics
database, which is maintained by the Department of
Health. Practices were grouped into quintiles of equal
size on the basis of the level of area deprivation in the
census super-output area (a standard, stable unit of
geography used in the UK for statistical analysis; average
population 7200) where they were located, with data from
the Index of Deprivation 2004.20
We calculated the odds of
practices from each quintile being in the top and bottom
performing 5% of practices with respect to achievement
and rates of exclusion by logistic regression. We estimated
the associations of practice-level characteristics with
practice achievement, exclusion of patients, and changes
in these outcomes with multiple linear regressions.
These analyses controlled for missing indicators,
heterogeneity of variance, and clustering of practices,
and we made checks on the robustness of the results to
model specifications (webappendix). All variables were
divided by their standard deviations, thus regression
coefficients show the increase in standard deviations of
the outcome for one standard deviation increase in
predictor variables. All statistical analyses were done with
Stata software (version 9).
Achievement data for 2004–05, 2005–06, and 2006–07
were available for 8277 general practices in England.
Practices were excluded from the study if they had fewer
(164 practices), complete exclusion data were not available
(172 practices), or if the practice population changed in
size by 25% or more (258 practices). Our main results are
drawn from 7637 practices, providing care for more than
49 million patients. We undertook subanalyses for
excluded practices (webappendix).
Role of the funding source
There was no funding source for this study. The
corresponding author had full access to all the data in the
study and had fi nal responsibility for the decision to
submit for publication.
Results
The median overall reported achievement—the propor-
tion of patients who were deemed eligible by the prac-
tices for whom the targets were achieved—was 85·1%
(IQR 79·0–89·1) in year 1, 89·3% (86·0–91·5) in year 2,
and 90·8% (88·5–92·6) in year 3. Increases in
achievement between years were significant (p<0·0001
in all cases). Although average levels of achievement in-
creased over time, variation in achieve ment
diminished.
In year 1, progressively lower levels of achievement
were associated with increased levels of area deprivation
(fi gure 1). Median achievement ranged from 86·8%
(IQR 82·2–89·6) for quintile 1 (least deprived) to 82·8%
Overallreportedachievement(%)
Year 1 (2004–05)
0
20
40
60
80
100
Year 2 (2005–06) Year 3 (2006–07)
Quality and outcome framework year
Quintile 1
Quintile 2
Quintile 3
Quintile 4
Quintile 5
Figure 1: Distribution of scores for overall reported achievement by deprivation quintile for year 1 (2004–05) to year 3 (2006–07)
Central line shows median achievement and box shows interquartile range; whiskers represent range of achievement scores. Circles represent statistical outliers—
ie, individual practices with achievement scores outside the range: first quartile–(1·5×IQR) to third quartile+(1·5×IQR).
most deprived
most affluent
Articles
Effect of financial incentives on inequalities in the delivery of
primary clinical care in England: analysis of clinical activity
indicators for the quality and outcomes framework
Tim Doran, Catherine Fullwood, Evangelos Kontopantelis, David Reeves
Summary
Background The quality and outcomes framework is a financial incentive scheme that remunerates general practices
in the UK for their performance against a set of quality indicators. Incentive schemes can increase inequalities in the
delivery of care if practices in affluent areas are more able to respond to the incentives than are those in deprived
areas. We examined the relation between socioeconomic inequalities and delivered quality of clinical care in the first
3 years of this scheme.
Methods We analysed data extracted automatically from clinical computing systems for 7637 general practices in
England, data from the UK census, and data for characteristics of practices and patients from the 2006 general medical
statistics database. Practices were grouped into equal-sized quintiles on the basis of area deprivation in their locality.
We calculated overall levels of achievement, defined as the proportion of patients who were deemed eligible by the
Lancet 2008; 372: 728–36
Published Online
August 12, 2008
DOI:10.1016/S0140-
6736(08)61123-X
See Comment page 692
National Primary Care Research
and Development Centre,
University of Manchester,
Manchester, UK (T Doran MD,
C Fullwood PhD,
E Kontopantelis PhD,
Kontopantelis (IPH) Variation and financial incentives 25 September 2013
Trends of prior achievement and 2006-7 expectations
Representative sample of 42 practices
By 2007 the rate of
improvement had slowed for
all three conditions
Quality of care for
non-incentivised aspects
declined for asthma and CHD
No significant changes on
access to care or on
interpersonal aspects of care
Continuity of care reduced
immediately after the
introduction of the scheme
QOF accelerated short-term
improvements
The new engl and jour nal of medicine
incentives as compared with those that were not.
in the post-introductio
pre-introduction period
ly (P = 0.06). However,
cant when calculated
strapping method (P =
(P = 0.03), and in abso
ity score for aspects of
were not linked to ince
whereas the quality sco
to incentives increased
ate effect of pay for p
between care that wa
linked with incentives
subsequently diverged
vs. pre-introduction pe
duction period vs. intr
with the mean score f
to incentives declining
score for care that wa
creasing. Trends in d
at any time according
linked to incentives.
Communication, Wait
and Continuity of Ca
The percentages of pat
within 48 hours, as w
the physician-commu
significant changes in
declined significantly
pay for performance (
this lower level (Table
Estimated Overall Eff
for Performance
For outcomes in whic
pay for performance a
improvement, we used
rupted time-series ana
of the increase in sco
from the trend in th
(back-transforming th
analysis, with estimat
As compared with the
ment based on the pre-
for-performance schem
22p3
90
Score
85
80
70
65
55
75
60
0
1998 1999 2000 2001 2002 2003 2007200620052004
Coronary
heart disease
Asthma
Diabetes
Year
B
A
AUTHOR:
FIGURE:
JOB:
4-C
H/T
RETAKE
SIZE
ICM
CASE
EMail Line
H/T
Combo
Revised
AUTHOR, PLEASE NOTE:
Figure has been redrawn and type has been reset.
Please check carefully.
REG F
Enon
1st
2nd
3rd
Campbell
1 of 2
xx-xx-09
ARTIST: ts
360xx ISSUE:
100
Score
90
80
60
50
20
70
40
30
0
1998 1999 2000 2001 2002 2003 2007200620052004
Communication
with physicians
Continuity of care
Able to get an appointment
within 48 hr (particular doctor)
Able to get an appointment
within 48 hr (any doctor)
Year
Figure 1. Mean Scores for the Quality of Care at the Practice Level, 1998–2007.
Panel A shows scores for the quality of care provided for coronary heart
disease, asthma, and diabetes. Quality scores range from 0% (no quality
indicator was met for any patient) to 100% (all quality indicators were met
for all patients). Panel B shows scores for patients’ perceptions of commu-
nication with physicians, access to care, and continuity of care. Communi-
cation was assessed by asking seven questions, with the answers scored on
a six-point scale ranging from “very poor” to “excellent”; continuity of care
was assessed with the use of the same six-point scale and a single question:
“How often do you see your usual doctor?” Access to care was scored as
the percentage of patients who reported that they were able to get an ap-
pointment within 48 hours. All scores were rescaled to range from 0 to 100.
special article
The new engl and jour nal of medicine
Effects of Pay for Performance
on the Quality of Primary Care in England
Stephen M. Campbell, Ph.D., David Reeves, Ph.D., Evangelos Kontopantelis, Ph.D.,
Bonnie Sibbald, Ph.D., and Martin Roland, D.M.
From the National Primary Care Research
and Development Centre, University of
Abstr act
Background
A pay-for-performance scheme based on meeting targets for the quality of clinical
care was introduced to family practice in England in 2004.
Kontopantelis (IPH) Variation and financial incentives 25 September 2013
Does the size of the practice matter?
All 8000+ English practices
In y1 smallest practices had
the lowest median reported
achievement rates
Performance improved over
time; smallest practices
improved at the fastest rate
Caught up by y3 but displayed
more variation in performance
Small practices represented
among best and worst
QOF reduced variation in
performance and differences
between large and small
practices
e339
proportions over time.
Reported achievement
The median overall reported achievement, the
proportion of patients deemed appropriate by the
practice for whom the targets were achieved, was
85.2% in year 1, 89.3% in year 2, and 90.9% in
year 3. Increases in achievement between years
were statistically significant (P<0.005 in all cases).
Median reported achievement in year 1 varied with
patients, year 1 (2004–2005)
to year 3 (2006–2007).
100
80
60
40
20
0
2004/2005 2005/2006 2006/2007
QOF year
list size 1000–1999
2000–2999
3000–3999
4000–5999
6000–7999
8000–9999
10000–11999
12000 or more
Overallreportedachievement
Figure 2. Distribution of
practice scores for overall
reported achievement by
number of patients, year 1
(2004–2005) to year 3
(2006–2007).
Central white line shows median scores and box shows interquartile range (IQR); whiskers
represent range of scores. Circles represent statistical outliers — that is, individual practices
with points scores outside the range: first quartile — (1.5 × IQR) + (1.5 × IQR).
ABSTRACT
Background
Small general practices are often perceived to provide
worse care than larger practices.
Aim
To describe the comparative performance of small
INTRODUCTION
Small general practices in the UK, particularly those
that are single handed, are often accused of
providing poor-quality care. The 2000 NHS Plan cited
a need to ‘confirm that single-handed (solo)
practices are offering high standards’.1
The Shipman
Inquiry identified advantages and disadvantages
T Doran, S Campbell, C Fullwood, et al
Performance of small general
practices under the UK’s Quality
and Outcomes Framework
Tim Doran, Stephen Campbell, Catherine Fullwood,
Evangelos Kontopantelis and Martin RolandBJGP 2010
Kontopantelis (IPH) Variation and financial incentives 25 September 2013
Changes in patient experiences
42 practices, random samples of chronic condition and all patients
No changes in 2003-7
quality of care for
communication, nursing
care, coordination &
overall satisfaction
Aspects of access
improved for chronic
disease patients only
Both samples seeing their
usual GP less & less
satisfied in continuity
Related to incentives to
provide rapid
appointments
ANNALS OF FAMILY MEDICINE ✦
WWW.ANNFAMMED.ORG ✦
VOL. 8, NO. 6 ✦
NOVEMBER/DECEMBER 2010
502
of-access items (P >.05), including ability to see a
particular physician or any physician within 48 hours. Patients Randomly Sampled From
Registered Lists
Results for patients randomly sampled from practice
lists matched those for patients with chronic illness in
all aspects except the speed-of-access items: no signifi-
cant changes over time were observed in any of these
items. The only significant changes from 2003 to 2007
were in regard to continuity of care, with a reduction
in how often patients reported being able to see their
Table 2. Response Rates for Patient Surveys
Patient Group
2003
% (n)
2005
% (n)
2007
% (n)
Chronic illness samples 55 (1,092) 52 (1,040) 50 (922)
Random samples of
registered patients
47 (3,873) 45 (3,601) 37 (3,104)
Table 3. Summary of Practice Mean GPAQ Scale and Individual Item Scores 2003, 2005, and 2007,
for Cross-Sectional Samples of Patients With Chronic Illness and Random Samples of Adult Patients
GPAQ Scale and Item
Samples of Patients
With Chronic Illness
Mean (SD)a
Samples of Randomly
Selected Patients
Mean (SD)a
2003 2005 2007 2003 2005 2007
Communication scale 74.5 (10.1) 74.5 (9.3) 76.0 (8.5) 69.5 (10.0) 68.4 (9.4) 69.9 (8.9)
Coordination scale 72.1 (7.4) 71.0 (5.8) 73.0 (5.9) 67.0 (5.8) 68.6 (5.1) 68.3 (6.1)
Nursing care scale 76.0 (6.1) 76.1 (6.0) 75.3 (8.1) 73.9 (6.2) 73.4 (5.3) 72.9 (7.1)
Overall satisfaction scale 81.6 (8.0) 80.6 (8.6) 81.3 (7.7) 75.2 (9.2) 74.7 (10.6) 75.6 (7.9)
Item: In general, how often do you see your
usual doctor (continuity of care)?
77.2 (8.0) 74.9 (9.4) 70.4 (9.6) 68.2 (13.1) 62.8 (13.5) 62.5 (11.6)
Item: Rating of how often patients get to see
their usual doctor (rating of continuity of care)
71.5 (9.8) 69.1 (9.9) 67.4 (11.5) 64.6 (13.1) 61.0 (12.2) 61.2 (10.4)
Item: Do you get an appointment with a particu-
lar doctor within 48 hours?
36.9 (29.5) 38.7 (26.3) 37.0 (22.6) 33.4 (26.2) 35.9 (25.1) 32.3 (21.0)
Item: Rating of how quickly an appointment
can be made with a particular doctor in the
practice
57.3 (17.7) 58.0 (14.1) 56.6 (15.6) 50.0 (18.6) 52.2 (16.0) 53.0 (13.6)
Item: Do you get an appointment with any doc-
tor within 48 hours?
64.5 (23.9) 68.0 (22.6) 67.2 (19.9) 61.5 (24.2) 63.4 (21.0) 63.8 (22.4)
Item: Rating of how quickly an appointment can
be made with any doctor in the practice
65.2 (15.2) 64.5 (13.8) 65.5 (14.5) 59.2 (17.2) 61.2 (14.2) 62.4 (13.1)
Item: If you need an urgent appointment can you
get one on the same day?
81.8 (17.7) 81.2 (15.5) 82.2 (16.8) 79.6 (17.1) 78.2 (17.5) 79.4 (18.8)
GPAQ=General Practice Assessment Questionnaire.
Note: See the Appendix for a description of how the scales were scored.
a
Figures relate to raw practice-level scores (mean and standard deviation of practice means).
13/09/2013 Changes in Patient Experiences of PrimaryCare During Health Service Reforms
+
The Annals of Family Medicine
www.annfammed.org
doi: 10.1370/afm.1145
Ann Fam Med November 1, 2010 vol. 8 no. 6 499-506
Changes in Patient Experiences of
Primary Care During Health Service
Reforms in England Between 2003 and
2007
Stephen M. Campbell, PhD1, Evangelos Kontopantelis, PhD1,
David Reeves, PhD1, Jose M. Valderas, PhD1, Ella Gaehl, MPhil1,
Nicola Small, MPhil1 and Martin O. Roland, DM2
Author Affiliations
CORRESPONDING AUTHOR: Stephen Campbell, PhD, National Primary Care
Research and Development Centre, University of Manchester, Williamson Bldg,
Kontopantelis (IPH) Variation and financial incentives 25 September 2013
Patient satisfaction
2007-8 GP Access Survey, all English practices
Young, Asian, working FT, with
long commuting times: lowest
levels of satisfaction and
experience of access
Ability to take time off to visit
GP eliminated the
disadvantage in access
Patients in small practices
more positive for all aspects of
access; except opening hours
Positive access to care
associated with higher QOF
scores and slightly lower rates
of emergency admission
0
20
40
60
80
100
%ofpositiveresponses
<1
1−2
2−3
3−4
4−6
6−88−1010−12>=12
Phone access
0
20
40
60
80
100
%ofpositiveresponses
<1
1−2
2−3
3−4
4−6
6−88−1010−12>=12
Appointment within 2 days
0
20
40
60
80
100
%ofpositiveresponses
<1
1−2
2−3
3−4
4−6
6−88−1010−12>=12
Advance appointment (>2 days)
0
20
40
60
80
100
%ofpositiveresponses
<1
1−2
2−3
3−4
4−6
6−88−1010−12>=12
Appointment with a particular GP
Practice size in 1,000s of patients
by practice list size
Satisfaction & positive experience
RESEARCH ARTICLE Open Access
Patient experience of access to primary care:
identification of predictors in a national patient
survey
Evangelos Kontopantelis1*
, Martin Roland2
, David Reeves1
Abstract
Background: The 2007/8 GP Access Survey in England measured experience with five dimensions of access:
getting through on the phone to a practice, getting an early appointment, getting an advance appointment,
Kontopantelis et al. BMC Family Practice 2010, 11:61
http://www.biomedcentral.com/1471-2296/11/61
Kontopantelis (IPH) Variation and financial incentives 25 September 2013
Advising NICE on removing indicators
All English practices, 2004/5 to 2009/10
Indicators should be removed on
statistical criteria and the economics
of incentives
Replaced with other indicators to
drive improvement in other areas
It is unknown what will happen to
the withdrawn indicators
BMJ | 24 APRIL 2010 | VOLUME 340 899
ANALYSIS
Increasing numbers of countries are using indi-
cators to evaluate the quality of clinical care,
with some linking payment to achievement.1
For performance frameworks to remain effective
the indicators need to be regularly reviewed. The
frameworks cannot cover all clinical areas, and
achievement on chosen indicators will even-
tually reach a ceiling beyond which further
improvement is not feasible.2 3
However, there
has been little work on how to select indictors for
replacement. The Department of Health decided
in 2008 that it would regularly replace indicators
in the national primary care pay for performance
scheme, the Quality and Outcomes Framework,4
making a rigorous approach to removal a prior-
ity. We draw on our previous work on pay for
performance5 6
and our current work advising
the National Institute for Health and Clinical
Excellence (NICE) on the Quality and Outcomes
Framework to suggest what should be consid-
ered when planning to remove indicators from
a clinical performance framework.
First UK decisions
The Quality and Outcomes Framework cur-
rently includes 134 indicators for which gen-
eral practices can earn up to a total of 1000
points. Negotiations between the Department
of Health and the BMA’s General Practitioners
Committee last autumn led to an agreement to
remove eight clinical indicators worth 28 points
in April 2011 (table 1). The eight indicators are
all process measures and reward actions such as
taking blood pressure or taking blood to measure
cholesterol, glucose, or creatinine concentra-
tions for people with relevant chronic diseases.
The framework rewards the action itself rather
than a clinically informed response to results or
intermediate outcomes such as better control of
blood pressure or cholesterol levels. It is there-
fore not surprising that achievement of these
process indicators is high (median >95% and
interquartile range <4.5%) with little change in
rates or variation across practices since 2005-6,
the second year of the Quality and Outcomes
Framework.
In many schemes, including the Quality and
Outcomes Framework, providers can “except”
certain patients from inclusion in the denomi-
nator figures for an indicator on grounds such as
extreme frailty or contraindications to a specified
drug. Exception reporting rates are also low for
these eight indicators (median <5% and inter-
quartile range <3%).
How to identify when a performance
indicator has run its course
In April 2011 eight clinical indicators will be removed from the UK Quality and Outcomes
Framework. David Reeves and colleagues explain why they were chosen and suggest
a rationale for future decisions
National achievement and exception rates for indicators that are to be removed from the Quality and Outcomes Frameworkin 20117
Indicator (measurement of ) Condition
Median (interquartile range) achievement (%) Median (interquartile range) rate of exceptions (%) Paired
indicator*2005-6 2006-7 2007-8 2005-6 2006-7 2007-8
Bloodpressure Coronaryheartdisease 98.2 (96.7-99.3) 98.5 (97.2-99.5) 98.4(97.1-99.4) 0.8 (0-1.8) 0.8 (0-1.7) 0.7 (0-1.6) Yes
Haemoglobin A1c
Diabetes 97.4 (95.1-98.8) 97.8 (95.9-99.0) 97.7 (96.0-98.9) 2.7 (1.4-4.4) 2.5 (1.3-4.2) 2.4 (1.2-3.9) Yes
Bloodpressure Diabetes 98.8 (97.6-99.7) 99.0 (98.0-100) 98.9 (97.9-99.6) 1.1 (0.3-2.2) 1.0 (0.3-2.1) 1.0 (0.3-2.1) Yes
Serum creatinine Diabetes 96.7 (94.1-98.3) 97.4 (95.3-98.7) 97.4 (95.6-98.7) 1.9 (0.9-3.4) 1.7 (0.8-3.2) 1.6 (0.7-3.1) No
Totalcholesterol Diabetes 96.4 (93.8-98.1) 96.9 (94.8-98.3) 96.8 (94.8-98.2) 2.2 (1.1-3.9) 2.1 (1.0-3.8) 2.0 (0.9-3.6) Yes
Serum creatinine andthyroid
stimulating hormone
Mentalhealth (lithium) 100 (100-100) 100 (100-100) 100 (100-100) 0 (0-0) 0 (0-0) 0 (0-0) No
Bloodpressure Stroke 97.4 (95.1-100) 97.7 (95.8-100) 97.6 (95.8-99.5) 1.3 (0-3.3) 1.2 (0-2.9) 1.1 (0-2.7) Yes
Thyroidfunction Hypothyroidism 96.8 (94.5-98.7) 96.7 (94.5-98.5) 96.5 (94.3-98.3) 0 (0-0.9) 0 (0-0.9) 0 (0-0.8) No
*Paired indicators relate to control of the relevant measure—for example, the indicator that focuses on recording blood pressure in patients with coronary heart disease, is paired with another
indicator that rewards on the basis of the proportion of patients whose last blood pressure reading was ≤150/90 mm Hg.
BMJ | 24 april 2010 | Volume 340 				 899
tually reach a ceiling beyond which further
improvement is not feasible.2 3
However, there
has been little work on how to select indictors for
replacement. The Department of Health decided
in 2008 that it would regularly replace indicators
in the national primary care pay for performance
scheme, the Quality and Outcomes Framework,4
making a rigorous approach to removal a prior-
ity. We draw on our previous work on pay for
performance5 6
and our current work advising
the National Institute for Health and Clinical
Excellence (NICE) on the Quality and Outcomes
Framework to suggest what should be consid-
ered when planning to remove indicators from
a clinical performance framework.
First UK decisions
The Quality and Outcomes Framework cur-
rently includes 134 indicators for which gen-
eral practices can earn up to a total of 1000
points. Negotiations between the Department
of Health and the BMA’s General Practitioners
­Committee last autumn led to an agreement to
remove eight clinical indicators worth 28 points
in April 2011 (table 1). The eight indicators are
all process measures and reward actions such as
taking blood pressure or taking blood to measure
­cholesterol, glucose, or creatinine concentra-
tions for people with relevant chronic diseases.
The framework rewards the action itself rather
than a clinically informed response to results or
intermediate outcomes such as better control of
blood pressure or cholesterol levels. It is there-
fore not surprising that achievement of these
process indicators is high (median >95% and
interquartile range <4.5%) with little change in
rates or variation across practices since 2005-6,
the second year of the Quality and Outcomes
Framework.
In many schemes, including the Quality and
Outcomes Framework, providers can “except”
certain patients from inclusion in the denomi-
nator figures for an indicator on grounds such as
extreme frailty or contraindications to a specified
drug. Exception reporting rates are also low for
these eight indicators (median <5% and inter-
quartile range <3%).
National achievement and exception rates for indicators that are to be removed from the Quality and Outcomes Frameworkin 20117
Indicator (measurement of ) Condition
Median (interquartile range) achievement (%) Median (interquartile range) rate of exceptions (%) Paired
indicator*2005-6 2006-7 2007-8 2005-6 2006-7 2007-8
Bloodpressure Coronaryheartdisease 98.2 (96.7-99.3) 98.5 (97.2-99.5) 98.4(97.1-99.4) 0.8 (0-1.8) 0.8 (0-1.7) 0.7 (0-1.6) Yes
Haemoglobin A1c
Diabetes 97.4 (95.1-98.8) 97.8 (95.9-99.0) 97.7 (96.0-98.9) 2.7 (1.4-4.4) 2.5 (1.3-4.2) 2.4 (1.2-3.9) Yes
Bloodpressure Diabetes 98.8 (97.6-99.7) 99.0 (98.0-100) 98.9 (97.9-99.6) 1.1 (0.3-2.2) 1.0 (0.3-2.1) 1.0 (0.3-2.1) Yes
Serum creatinine Diabetes 96.7 (94.1-98.3) 97.4 (95.3-98.7) 97.4 (95.6-98.7) 1.9 (0.9-3.4) 1.7 (0.8-3.2) 1.6 (0.7-3.1) No
Totalcholesterol Diabetes 96.4 (93.8-98.1) 96.9 (94.8-98.3) 96.8 (94.8-98.2) 2.2 (1.1-3.9) 2.1 (1.0-3.8) 2.0 (0.9-3.6) Yes
Serum creatinine andthyroid
stimulating hormone
Mentalhealth (lithium) 100 (100-100) 100 (100-100) 100 (100-100) 0 (0-0) 0 (0-0) 0 (0-0) No
Bloodpressure Stroke 97.4 (95.1-100) 97.7 (95.8-100) 97.6 (95.8-99.5) 1.3 (0-3.3) 1.2 (0-2.9) 1.1 (0-2.7) Yes
Thyroidfunction Hypothyroidism 96.8 (94.5-98.7) 96.7 (94.5-98.5) 96.5 (94.3-98.3) 0 (0-0.9) 0 (0-0.9) 0 (0-0.8) No
*Paired indicators relate to control of the relevant measure—for example, the indicator that focuses on recording blood pressure in patients with coronary heart disease, is paired with another
indicator that rewards on the basis of the proportion of patients whose last blood pressure reading was ≤150/90 mm Hg.
Kontopantelis (IPH) Variation and financial incentives 25 September 2013
Non-incentivised aspects of care
Sample of 148 representative practices from the CPRD
Achievement rates improved
for most indicators in the
pre-incentive period
Significant initial gains in
incentivised indicators but no
gains in later years
No overall effect on the rate of
improvement for non
incentivised indicators in
2004-5
But by 2006-7 achievement
rates significantly below those
predicted by pre-incentive
trends
Figure
Mean achievement rate of 148 general practices for qua
grouped by activity and whether they were incentivised
mean rate is the mean of the adjusted means for the in
Effect of financial incentives on incentivised and
non-incentivised clinical activities: longitudinal
analysis of data from the UK Quality and Outcomes
Framework
Tim Doran clinical research fellow1
, Evangelos Kontopantelis research associate1
, Jose M Valderas
clinical lecturer 2
, Stephen Campbell senior research fellow 1
, Martin Roland professor of health
services research3
, Chris Salisbury professor of primary healthcare4
, David Reeves senior research
fellow 1
1
National Primary Care Research and Development Centre, University of Manchester, Manchester M13 9PL, UK; 2
NIHR School for Primary Care
Research, Department of Primary Health Care, University of Oxford, Oxford OX3 7LF; 3
General Practice and Primary Care Research Unit, University
of Cambridge, Cambridge CB2 0SR; 4
Academic Unit of Primary Health Care, University of Bristol, Bristol BS8 2AA
Abstract
Objective To investigate whether the incentive scheme for UK general
practitioners led them to neglect activities not included in the scheme.
Design Longitudinal analysis of achievement rates for 42 activities (23
included in incentive scheme, 19 not included) selected from 428
identified indicators of quality of care.
Setting 148 general practices in England (653 500 patients).
Main outcome measures Achievement rates projected from trends in
the pre-incentive period (2000-1 to 2002-3) and actual rates in the first
Introduction
Over the past two decades funders and policy makers worldwide
have experimented with initiatives to change physicians’
behaviour and improve the quality and efficiency of medical
care.1
Success has been mixed, and attention has recently turned
to payment mechanism reform, in particular offering direct
financial incentives to providers for delivering high quality
care.2
In 2004 in the UK the Quality and Outcomes Framework
(QOF) was introduced—a mechanism intended to improve
BMJ 2011;342:d3590 doi: 10.1136/bmj.d3590 Page 1 of 12
Research
RESEARCH
Kontopantelis (IPH) Variation and financial incentives 25 September 2013
Reasons for exception reporting patients
All English practices in 2008-9
Median exception rate was 2.7% (IQR 1.9-3.9%) overall and
0.44% (0.14-1.1%) for informed dissent
Common reasons logistical (40.6%), clinical contraindication
(18.7%), patient informed dissent (30.1%)
Higher rates associated with: larger practices, higher deprivation,
failure to secure maximum remuneration in previous year
Cost of the provision relatively low at £0.58 per patient (£31m)
Relatively few patients excluded for informed dissent, suggesting
that the incentivised activities were broadly acceptable to patientsFigures
Fig 1 Proportion of patients exception reported by indicator and reason, 2008-9. For 37 indicators for which reasons for
exception reporting were ascribable (see table 1). Indicators ordered by type of activity (measurement or outcome) and by
rate of exception reporting attributable to informed dissent
BMJ 2012;344:e2405 doi: 10.1136/bmj.e2405 (Published 17 April 2012) Page 11 of 11
RESEARCH
Exempting dissenting patients from pay for
performance schemes: retrospective analysis of
exception reporting in the UK Quality and Outcomes
Framework
OPEN ACCESS
Tim Doran clinical research fellow
1
, Evangelos Kontopantelis research fellow
1
, Catherine Fullwood
research associate
2
, Helen Lester professor of primary care
3
, Jose M Valderas clinical lecturer
4
,
Stephen Campbell senior research fellow
1
1
Health Sciences Research Group-Primary Care, University of Manchester, Manchester M13 9PL, UK; 2
Manchester Academic Health Science
Centre, Central Manchester University Hospitals NHS Foundation Trust, University of Manchester; 3
School of Health and Population Sciences,
University of Birmingham, Birmingham, UK; 4
NIHR School for Primary Care Research, Health Services and Policy Research Group, Department
of Primary Care Health Sciences, University of Oxford, Oxford, UK
Abstract
Objective To examine the reasons why practices exempt patients from
the UK Quality and Outcomes Framework pay for performance scheme
(exception reporting) and to identify the characteristics of general
Conclusions The provision to exception report enables practices to
exempt dissenting patients without being financially penalised. Relatively
few patients were excluded for informed dissent, however, suggesting
that the incentivised activities were broadly acceptable to patients.
BMJ 2012;344:e2405 doi: 10.1136/bmj.e2405 (Published 17 April 2012) Page 1 of 11
Research
RESEARCH
Kontopantelis (IPH) Variation and financial incentives 25 September 2013
Changes to the incentives
All English practices, 2004-5 to 2009-10
Four influenza immunisation
indicators for CHD, COPD,
diabetes and stroke
Upper threshold increased by
5% only for CHD in 2006-7
The increase led to increase in
the % of immunised CHD
patients by 0.41% but also to
exception reporting by 0.26%
Making quality targets more
demanding can lead to
improvement in quality of care
but can also have other
consequences
Minimum
threshold
y1/2
Mminimum
threshold
y3/5
Maximum
threshold
y1/2
Maximum
threshold
y3/5
02004006008001000
Numberofpractices
0 20 40 60 80 100
Percentage of patients
08/09 07/08 06/07 05/06 04/05
CHD 12
Reported achievement
Family Doctor Responses to Changes in
Incentives for Influenza Immunization
under the U.K. Quality and Outcomes
Framework Pay-for-Performance
Scheme
Evangelos Kontopantelis, Tim Doran, Hugh Gravelle, Rosalind
Goudie, Luigi Siciliani, and Matt Sutton
Objective. To analyze the effect of setting higher targets, in a primary care pay-for-
performance scheme, on rates of influenza immunization and exception reporting.
© Health Research and Educational Trust
DOI: 10.1111/j.1475-6773.2011.01362.x
RESEARCH ARTICLE
Health Services Research
Health Services Research, 2012
Kontopantelis (IPH) Variation and financial incentives 25 September 2013
Patient level diabetes care
Sample of 148 representative practices from the CPRD
In 2004-5 quality improved
over-and-above this
pre-incentive trend by 14.2%
By 2006-7 the improvement
above trend was smaller at 7.3
Levels of care varied
significantly for sex, age, years
of previous care, number of
co-morbid conditions
Recorded quality of primary care for
patients with diabetes in England
before and after the introduction
of a financial incentive scheme:
a longitudinal observational study
Evangelos Kontopantelis,1
David Reeves,1
Jose M Valderas,2,3
Stephen Campbell,1
Tim Doran1
▸ An additional data is
published online only. To view
this file please visit the journal
online (http://bmjqs.bmj.com)
1
Health Sciences Primary Care
Research Group, University of
ABSTRACT
Background The UK’s Quality and Outcomes
Framework (QOF) was introduced in 2004/5,
linking remuneration for general practices to
recorded quality of care for chronic conditions,
years were more modest. Variation in care
between population groups diminished under
the incentives, but remained substantial in some
cases.
ORIGINAL RESEARCH
group.bmj.comon September 13, 2013 - Published byqualitysafety.bmj.comDownloaded from
Recorded QOF care did not vary significantly by area
deprivation before or after the introduction of the
incentivisation scheme. However, the effect of the inter-
vention did vary with area deprivation: patients attend-
ing practices from the most deprived quartile appear to
have gained less from the intervention compared with
patients in the most affluent quartile of practices, by
4.9% in 2004/5 and 3.8% in 2006/7.
There was significant variation in recorded QOF care
by practice diabetes prevalence rates, but the differences
Figure 2 Aggregate patient level Quality and Outcomes
Framework care and predictions based on the
pre-incentivisation trend.
on Sequalitysafety.bmj.comDownloaded from
2000/1 2001/2 2002/3 2003/4 2004/5 2005/6 2006/7
new diagno 44.7 50.4 56.5 65.3 73.4 74.2 74.3
1-4 years 48.4 53.9 59.4 71.1 80.9 83 83.2
5-9 years 46.4 51.9 56.8 69.1 78.7 81.4 81.8
10+ years 45.4 50 55.1 66.7 77.6 79.3 80.4
2000/1 2001/2 2002/3 2003/4 2004/5 2005/6 2006/7
new diagnoses 44.7 50.4 56.5 65.3 73.4 74.2 74.3
1-4 years 48.4 53.9 59.4 71.1 80.9 83 83.2
5-9 years 46.4 51.9 56.8 69.1 78.7 81.4 81.8
10+ years 45.4 50 55.1 66.7 77.6 79.3 80.4
40
45
50
55
60
65
70
75
80
85
90
aggregaterecordedQOFcarescore
Kontopantelis (IPH) Variation and financial incentives 25 September 2013
Clinical computer systems
All English practices, 2007-8 to 2010-11
Seven clinical computer
systems consistently active
collectively holding ≈ 99% of
the market share
System choice strongest
predictor of performance on
62 stable care indicators
Differences greatest for
intermediate outcome
indicators
Particular system
characteristics facilitate higher
quality of care, better data
recording or both?
North East
North West
London
West Midlands
Yorkshire & the Humber
South West
East Midlands
East of England
South Central
South East Coast
(85.4,85.7]
(85.1,85.4]
(84.8,85.1]
(84.5,84.8]
(84.2,84.5]
[83.9,84.2]
LV
Vision 3
ProdSysOneX
PCS
Synergy
Practice Manager
Premiere
NOTE: Chart size proportional to number of practices in area
Average practice scores by Strategic Health Authority, 2010−11
Overall population achievement (62 indicators)
and GP systems products
Relationship between quality of care
and choice of clinical computing
system: retrospective analysis of family
practice performance under the UK’s
quality and outcomes framework
Evangelos Kontopantelis,1,2
Iain Buchan,3
David Reeves,1,2
Kath Checkland,1
Tim Doran4
To cite: Kontopantelis E,
Buchan I, Reeves D, et al.
Relationship between quality
of care and choice of clinical
computing system:
retrospective analysis of
family practice performance
under the UK’s quality and
outcomes framework. BMJ
ABSTRACT
Objectives: To investigate the relationship between
performance on the UK Quality and Outcomes
Framework pay-for-performance scheme and choice of
clinical computer system.
Design: Retrospective longitudinal study.
Setting: Data for 2007–2008 to 2010–2011, extracted
from the clinical computer systems of general practices
ARTICLE SUMMARY
Article focus
▪ Practice and patient-level characteristics are
known predictors of quality of care, as measured
by the Quality and Outcomes Framework (QOF)
indicators.
▪ Various general practitioner (GP) clinical com-
Open Access Research
group.bmj.comon September 13, 2013 - Published bybmjopen.bmj.comDownloaded from
Kontopantelis (IPH) Variation and financial incentives 25 September 2013
Getting there...
Very high levels of initial
achievent leading to
overpayment
Still confusion about whether
the aim is to reward high
quality of care or to drive
improvement
It appears that the same levels
of care would have been met
eventually; QOF just took us
there quicker
050010001500
Numberofpractices
0 20 40 60 80 100
Percentage of patients
08/09 07/08 06/07 05/06 04/05
Overall, 48+2 (smoking) indicators
Reported achievement
Kontopantelis (IPH) Variation and financial incentives 25 September 2013
Getting there...
Reduced inequalities but negatively affected continuity and
aspects of non incentivised care
QOF led to bigger, better organised practices but patients do not
seem to like that
Exception reporting a cheap provision to ensure no patient
discrimination
Small changes in the scheme details can have big effects on
quality of care
The intervention effect varied by patient groups
Strongest predictor of achievement was clinical system
Kontopantelis (IPH) Variation and financial incentives 25 September 2013
What’s to be done with it?
good on paper but massive cost
Limit incentives to intermediate
outcome indicators only?
Remove the upper thresholds for
indicators, thereby reducing the
cost and driving improvement?
Re-negotiate the payment
platform for the same reason?
Bigger range of indicators and
only a random set assessed each
year?
Drop the whole scheme and
re-invest in other ventures?
Kontopantelis (IPH) Variation and financial incentives 25 September 2013
More questions
What happens when the incentive for an indicator is removed?
What is the effect of the incentivisation on harder outcomes?
mortality
complications (e.g. for diabetes)
What really happens with exceptions and is there any gaming?
Kontopantelis (IPH) Variation and financial incentives 25 September 2013
Thank you for listening!
Comments and questions: e.kontopantelis@manchester.ac.uk
Kontopantelis (IPH) Variation and financial incentives 25 September 2013

Mais conteúdo relacionado

Semelhante a Faculty showcase 2013 - Opening up clinical performance

Diabetes care in the time of Covid 19 2021 Prof Vinod Patel
Diabetes care in the time of Covid 19 2021 Prof Vinod PatelDiabetes care in the time of Covid 19 2021 Prof Vinod Patel
Diabetes care in the time of Covid 19 2021 Prof Vinod PatelVinod0901
 
Presentation to CCG - Capita Health Freakononics v3
Presentation to CCG - Capita Health Freakononics v3Presentation to CCG - Capita Health Freakononics v3
Presentation to CCG - Capita Health Freakononics v3Mike Thorogood
 
DR ARYA LUNG CANCER SCREENING 28 TH JAN.pptx
DR ARYA  LUNG CANCER SCREENING 28 TH JAN.pptxDR ARYA  LUNG CANCER SCREENING 28 TH JAN.pptx
DR ARYA LUNG CANCER SCREENING 28 TH JAN.pptxdranimesharya
 
NHS New Structure and Heatwaves
NHS New Structure and HeatwavesNHS New Structure and Heatwaves
NHS New Structure and HeatwavesGraham Atherton
 
Getting started at the national level from demonstration to spread
Getting started at the national level from demonstration to spreadGetting started at the national level from demonstration to spread
Getting started at the national level from demonstration to spreadProqualis
 
RCGP Scotland manifesto - fair version
RCGP Scotland manifesto - fair versionRCGP Scotland manifesto - fair version
RCGP Scotland manifesto - fair versionDavid Webster
 
4 integration and nhs value
4 integration and nhs value4 integration and nhs value
4 integration and nhs valueGreg Fell
 
St. David's Prophylaxis Program
St. David's Prophylaxis ProgramSt. David's Prophylaxis Program
St. David's Prophylaxis ProgramSCBHealth
 
Australia Lung Cancer Drugs Market Analysis Sample Report
Australia Lung Cancer Drugs Market Analysis Sample ReportAustralia Lung Cancer Drugs Market Analysis Sample Report
Australia Lung Cancer Drugs Market Analysis Sample ReportInsights10
 
Point of Care Diagnostics: Revenue Growth, New Entrants, Investment
Point of Care Diagnostics: Revenue Growth, New Entrants, InvestmentPoint of Care Diagnostics: Revenue Growth, New Entrants, Investment
Point of Care Diagnostics: Revenue Growth, New Entrants, InvestmentBruce Carlson
 
EPRD16 - LIvien Annemans reducing waste and inefficiencies in helathcare
EPRD16 - LIvien Annemans reducing waste and inefficiencies in helathcare EPRD16 - LIvien Annemans reducing waste and inefficiencies in helathcare
EPRD16 - LIvien Annemans reducing waste and inefficiencies in helathcare Cittadinanzattiva onlus
 
The size of the prize: doing things differently to prevent heart attacks and ...
The size of the prize: doing things differently to prevent heart attacks and ...The size of the prize: doing things differently to prevent heart attacks and ...
The size of the prize: doing things differently to prevent heart attacks and ...Innovation Agency
 
Getting to grips with Population Health - 28th Feb 2018
Getting to grips with Population Health - 28th Feb 2018Getting to grips with Population Health - 28th Feb 2018
Getting to grips with Population Health - 28th Feb 2018James Carter
 
operating theatre journal january 2015
operating theatre journal january 2015operating theatre journal january 2015
operating theatre journal january 2015Jonathon Squires
 
Right questions sustainability 100813
Right questions sustainability 100813Right questions sustainability 100813
Right questions sustainability 100813Ian Muchamore
 
Right questions sustainability 100813
Right questions sustainability 100813Right questions sustainability 100813
Right questions sustainability 100813Ian Muchamore
 
Newsletter Christmas Issue Dec. 2010 (1)
Newsletter Christmas Issue Dec. 2010 (1)Newsletter Christmas Issue Dec. 2010 (1)
Newsletter Christmas Issue Dec. 2010 (1)Judith Richardson
 
ISPOR Special Task Force on US Value Frameworks: A Non-US Perspective
ISPOR Special Task Force on US Value Frameworks: A Non-US PerspectiveISPOR Special Task Force on US Value Frameworks: A Non-US Perspective
ISPOR Special Task Force on US Value Frameworks: A Non-US PerspectiveOffice of Health Economics
 

Semelhante a Faculty showcase 2013 - Opening up clinical performance (20)

Diabetes care in the time of Covid 19 2021 Prof Vinod Patel
Diabetes care in the time of Covid 19 2021 Prof Vinod PatelDiabetes care in the time of Covid 19 2021 Prof Vinod Patel
Diabetes care in the time of Covid 19 2021 Prof Vinod Patel
 
Dec14
Dec14Dec14
Dec14
 
Presentation to CCG - Capita Health Freakononics v3
Presentation to CCG - Capita Health Freakononics v3Presentation to CCG - Capita Health Freakononics v3
Presentation to CCG - Capita Health Freakononics v3
 
DR ARYA LUNG CANCER SCREENING 28 TH JAN.pptx
DR ARYA  LUNG CANCER SCREENING 28 TH JAN.pptxDR ARYA  LUNG CANCER SCREENING 28 TH JAN.pptx
DR ARYA LUNG CANCER SCREENING 28 TH JAN.pptx
 
NHS New Structure and Heatwaves
NHS New Structure and HeatwavesNHS New Structure and Heatwaves
NHS New Structure and Heatwaves
 
Getting started at the national level from demonstration to spread
Getting started at the national level from demonstration to spreadGetting started at the national level from demonstration to spread
Getting started at the national level from demonstration to spread
 
RCGP Scotland manifesto - fair version
RCGP Scotland manifesto - fair versionRCGP Scotland manifesto - fair version
RCGP Scotland manifesto - fair version
 
4 integration and nhs value
4 integration and nhs value4 integration and nhs value
4 integration and nhs value
 
Lars Ryden. Debates en Cardiología
Lars Ryden. Debates en CardiologíaLars Ryden. Debates en Cardiología
Lars Ryden. Debates en Cardiología
 
St. David's Prophylaxis Program
St. David's Prophylaxis ProgramSt. David's Prophylaxis Program
St. David's Prophylaxis Program
 
Australia Lung Cancer Drugs Market Analysis Sample Report
Australia Lung Cancer Drugs Market Analysis Sample ReportAustralia Lung Cancer Drugs Market Analysis Sample Report
Australia Lung Cancer Drugs Market Analysis Sample Report
 
Point of Care Diagnostics: Revenue Growth, New Entrants, Investment
Point of Care Diagnostics: Revenue Growth, New Entrants, InvestmentPoint of Care Diagnostics: Revenue Growth, New Entrants, Investment
Point of Care Diagnostics: Revenue Growth, New Entrants, Investment
 
EPRD16 - LIvien Annemans reducing waste and inefficiencies in helathcare
EPRD16 - LIvien Annemans reducing waste and inefficiencies in helathcare EPRD16 - LIvien Annemans reducing waste and inefficiencies in helathcare
EPRD16 - LIvien Annemans reducing waste and inefficiencies in helathcare
 
The size of the prize: doing things differently to prevent heart attacks and ...
The size of the prize: doing things differently to prevent heart attacks and ...The size of the prize: doing things differently to prevent heart attacks and ...
The size of the prize: doing things differently to prevent heart attacks and ...
 
Getting to grips with Population Health - 28th Feb 2018
Getting to grips with Population Health - 28th Feb 2018Getting to grips with Population Health - 28th Feb 2018
Getting to grips with Population Health - 28th Feb 2018
 
operating theatre journal january 2015
operating theatre journal january 2015operating theatre journal january 2015
operating theatre journal january 2015
 
Right questions sustainability 100813
Right questions sustainability 100813Right questions sustainability 100813
Right questions sustainability 100813
 
Right questions sustainability 100813
Right questions sustainability 100813Right questions sustainability 100813
Right questions sustainability 100813
 
Newsletter Christmas Issue Dec. 2010 (1)
Newsletter Christmas Issue Dec. 2010 (1)Newsletter Christmas Issue Dec. 2010 (1)
Newsletter Christmas Issue Dec. 2010 (1)
 
ISPOR Special Task Force on US Value Frameworks: A Non-US Perspective
ISPOR Special Task Force on US Value Frameworks: A Non-US PerspectiveISPOR Special Task Force on US Value Frameworks: A Non-US Perspective
ISPOR Special Task Force on US Value Frameworks: A Non-US Perspective
 

Mais de Evangelos Kontopantelis

Investigating the relationship between quality of primary care and premature ...
Investigating the relationship between quality of primary care and premature ...Investigating the relationship between quality of primary care and premature ...
Investigating the relationship between quality of primary care and premature ...Evangelos Kontopantelis
 
Re-analysis of the Cochrane Library data and heterogeneity challenges
Re-analysis of the Cochrane Library data and heterogeneity challengesRe-analysis of the Cochrane Library data and heterogeneity challenges
Re-analysis of the Cochrane Library data and heterogeneity challengesEvangelos Kontopantelis
 
Attikon 2014 - Software and model selection challenges in meta-analysis
Attikon 2014 - Software and model selection challenges in meta-analysisAttikon 2014 - Software and model selection challenges in meta-analysis
Attikon 2014 - Software and model selection challenges in meta-analysisEvangelos Kontopantelis
 
RSS 2013 - A re-analysis of the Cochrane Library data]
RSS 2013 - A re-analysis of the Cochrane Library data]RSS 2013 - A re-analysis of the Cochrane Library data]
RSS 2013 - A re-analysis of the Cochrane Library data]Evangelos Kontopantelis
 
SAPC 2013 - general practice clinical systems
SAPC 2013 - general practice clinical systemsSAPC 2013 - general practice clinical systems
SAPC 2013 - general practice clinical systemsEvangelos Kontopantelis
 
Internal 2013 - General practice clinical systems
Internal 2013 - General practice clinical systemsInternal 2013 - General practice clinical systems
Internal 2013 - General practice clinical systemsEvangelos Kontopantelis
 
Internal 2012 - Software and model selection challenges in meta-analysis
Internal 2012 - Software and model selection challenges in meta-analysisInternal 2012 - Software and model selection challenges in meta-analysis
Internal 2012 - Software and model selection challenges in meta-analysisEvangelos Kontopantelis
 
Internal 2012 - individual patient data meta-analysis
Internal 2012 - individual patient data meta-analysisInternal 2012 - individual patient data meta-analysis
Internal 2012 - individual patient data meta-analysisEvangelos Kontopantelis
 
Amsterdam 2012 - one stage meta-analysis
Amsterdam 2012 - one stage meta-analysisAmsterdam 2012 - one stage meta-analysis
Amsterdam 2012 - one stage meta-analysisEvangelos Kontopantelis
 
NIHR School for primary care showcase 2012 - financial incentives
NIHR School for primary care showcase 2012 - financial incentivesNIHR School for primary care showcase 2012 - financial incentives
NIHR School for primary care showcase 2012 - financial incentivesEvangelos Kontopantelis
 
RSS local 2012 - Software challenges in meta-analysis
RSS local 2012 - Software challenges in meta-analysisRSS local 2012 - Software challenges in meta-analysis
RSS local 2012 - Software challenges in meta-analysisEvangelos Kontopantelis
 
SAPC north 2010 - provider incentives for influenza immunisation
SAPC north 2010 - provider incentives for influenza immunisationSAPC north 2010 - provider incentives for influenza immunisation
SAPC north 2010 - provider incentives for influenza immunisationEvangelos Kontopantelis
 
HSRN 2010: incentivisation and non-incentivised aspects of care
HSRN 2010: incentivisation and non-incentivised aspects of careHSRN 2010: incentivisation and non-incentivised aspects of care
HSRN 2010: incentivisation and non-incentivised aspects of careEvangelos Kontopantelis
 
Internal 2010 - Patient Satisfaction with Primary Care
Internal 2010 - Patient Satisfaction with Primary CareInternal 2010 - Patient Satisfaction with Primary Care
Internal 2010 - Patient Satisfaction with Primary CareEvangelos Kontopantelis
 

Mais de Evangelos Kontopantelis (20)

Primary Care data signposting
Primary Care data signpostingPrimary Care data signposting
Primary Care data signposting
 
Investigating the relationship between quality of primary care and premature ...
Investigating the relationship between quality of primary care and premature ...Investigating the relationship between quality of primary care and premature ...
Investigating the relationship between quality of primary care and premature ...
 
Re-analysis of the Cochrane Library data and heterogeneity challenges
Re-analysis of the Cochrane Library data and heterogeneity challengesRe-analysis of the Cochrane Library data and heterogeneity challenges
Re-analysis of the Cochrane Library data and heterogeneity challenges
 
Attikon 2014 - Software and model selection challenges in meta-analysis
Attikon 2014 - Software and model selection challenges in meta-analysisAttikon 2014 - Software and model selection challenges in meta-analysis
Attikon 2014 - Software and model selection challenges in meta-analysis
 
Internal 2014 - data signposting
Internal 2014 - data signpostingInternal 2014 - data signposting
Internal 2014 - data signposting
 
Internal 2014 - Cochrane data
Internal 2014 - Cochrane dataInternal 2014 - Cochrane data
Internal 2014 - Cochrane data
 
RSS 2013 - A re-analysis of the Cochrane Library data]
RSS 2013 - A re-analysis of the Cochrane Library data]RSS 2013 - A re-analysis of the Cochrane Library data]
RSS 2013 - A re-analysis of the Cochrane Library data]
 
SAPC 2013 - general practice clinical systems
SAPC 2013 - general practice clinical systemsSAPC 2013 - general practice clinical systems
SAPC 2013 - general practice clinical systems
 
Internal 2013 - General practice clinical systems
Internal 2013 - General practice clinical systemsInternal 2013 - General practice clinical systems
Internal 2013 - General practice clinical systems
 
Internal 2012 - Software and model selection challenges in meta-analysis
Internal 2012 - Software and model selection challenges in meta-analysisInternal 2012 - Software and model selection challenges in meta-analysis
Internal 2012 - Software and model selection challenges in meta-analysis
 
Internal 2012 - individual patient data meta-analysis
Internal 2012 - individual patient data meta-analysisInternal 2012 - individual patient data meta-analysis
Internal 2012 - individual patient data meta-analysis
 
Amsterdam 2012 - one stage meta-analysis
Amsterdam 2012 - one stage meta-analysisAmsterdam 2012 - one stage meta-analysis
Amsterdam 2012 - one stage meta-analysis
 
SAPC 2012 - exception reporting
SAPC 2012 - exception reportingSAPC 2012 - exception reporting
SAPC 2012 - exception reporting
 
NIHR School for primary care showcase 2012 - financial incentives
NIHR School for primary care showcase 2012 - financial incentivesNIHR School for primary care showcase 2012 - financial incentives
NIHR School for primary care showcase 2012 - financial incentives
 
RSS 2012 - ipdforest
RSS 2012 - ipdforestRSS 2012 - ipdforest
RSS 2012 - ipdforest
 
RSS local 2012 - Software challenges in meta-analysis
RSS local 2012 - Software challenges in meta-analysisRSS local 2012 - Software challenges in meta-analysis
RSS local 2012 - Software challenges in meta-analysis
 
SAPC north 2010 - provider incentives for influenza immunisation
SAPC north 2010 - provider incentives for influenza immunisationSAPC north 2010 - provider incentives for influenza immunisation
SAPC north 2010 - provider incentives for influenza immunisation
 
HSRN 2010: incentivisation and non-incentivised aspects of care
HSRN 2010: incentivisation and non-incentivised aspects of careHSRN 2010: incentivisation and non-incentivised aspects of care
HSRN 2010: incentivisation and non-incentivised aspects of care
 
GPRD 2010
GPRD 2010GPRD 2010
GPRD 2010
 
Internal 2010 - Patient Satisfaction with Primary Care
Internal 2010 - Patient Satisfaction with Primary CareInternal 2010 - Patient Satisfaction with Primary Care
Internal 2010 - Patient Satisfaction with Primary Care
 

Último

development of diagnostic enzyme assay to detect leuser virus
development of diagnostic enzyme assay to detect leuser virusdevelopment of diagnostic enzyme assay to detect leuser virus
development of diagnostic enzyme assay to detect leuser virusNazaninKarimi6
 
Pests of mustard_Identification_Management_Dr.UPR.pdf
Pests of mustard_Identification_Management_Dr.UPR.pdfPests of mustard_Identification_Management_Dr.UPR.pdf
Pests of mustard_Identification_Management_Dr.UPR.pdfPirithiRaju
 
Vip profile Call Girls In Lonavala 9748763073 For Genuine Sex Service At Just...
Vip profile Call Girls In Lonavala 9748763073 For Genuine Sex Service At Just...Vip profile Call Girls In Lonavala 9748763073 For Genuine Sex Service At Just...
Vip profile Call Girls In Lonavala 9748763073 For Genuine Sex Service At Just...Monika Rani
 
Introduction to Viruses
Introduction to VirusesIntroduction to Viruses
Introduction to VirusesAreesha Ahmad
 
SAMASTIPUR CALL GIRL 7857803690 LOW PRICE ESCORT SERVICE
SAMASTIPUR CALL GIRL 7857803690  LOW PRICE  ESCORT SERVICESAMASTIPUR CALL GIRL 7857803690  LOW PRICE  ESCORT SERVICE
SAMASTIPUR CALL GIRL 7857803690 LOW PRICE ESCORT SERVICEayushi9330
 
Kochi ❤CALL GIRL 84099*07087 ❤CALL GIRLS IN Kochi ESCORT SERVICE❤CALL GIRL
Kochi ❤CALL GIRL 84099*07087 ❤CALL GIRLS IN Kochi ESCORT SERVICE❤CALL GIRLKochi ❤CALL GIRL 84099*07087 ❤CALL GIRLS IN Kochi ESCORT SERVICE❤CALL GIRL
Kochi ❤CALL GIRL 84099*07087 ❤CALL GIRLS IN Kochi ESCORT SERVICE❤CALL GIRLkantirani197
 
Proteomics: types, protein profiling steps etc.
Proteomics: types, protein profiling steps etc.Proteomics: types, protein profiling steps etc.
Proteomics: types, protein profiling steps etc.Silpa
 
COST ESTIMATION FOR A RESEARCH PROJECT.pptx
COST ESTIMATION FOR A RESEARCH PROJECT.pptxCOST ESTIMATION FOR A RESEARCH PROJECT.pptx
COST ESTIMATION FOR A RESEARCH PROJECT.pptxFarihaAbdulRasheed
 
pumpkin fruit fly, water melon fruit fly, cucumber fruit fly
pumpkin fruit fly, water melon fruit fly, cucumber fruit flypumpkin fruit fly, water melon fruit fly, cucumber fruit fly
pumpkin fruit fly, water melon fruit fly, cucumber fruit flyPRADYUMMAURYA1
 
Connaught Place, Delhi Call girls :8448380779 Model Escorts | 100% verified
Connaught Place, Delhi Call girls :8448380779 Model Escorts | 100% verifiedConnaught Place, Delhi Call girls :8448380779 Model Escorts | 100% verified
Connaught Place, Delhi Call girls :8448380779 Model Escorts | 100% verifiedDelhi Call girls
 
High Profile 🔝 8250077686 📞 Call Girls Service in GTB Nagar🍑
High Profile 🔝 8250077686 📞 Call Girls Service in GTB Nagar🍑High Profile 🔝 8250077686 📞 Call Girls Service in GTB Nagar🍑
High Profile 🔝 8250077686 📞 Call Girls Service in GTB Nagar🍑Damini Dixit
 
Pests of cotton_Sucking_Pests_Dr.UPR.pdf
Pests of cotton_Sucking_Pests_Dr.UPR.pdfPests of cotton_Sucking_Pests_Dr.UPR.pdf
Pests of cotton_Sucking_Pests_Dr.UPR.pdfPirithiRaju
 
Module for Grade 9 for Asynchronous/Distance learning
Module for Grade 9 for Asynchronous/Distance learningModule for Grade 9 for Asynchronous/Distance learning
Module for Grade 9 for Asynchronous/Distance learninglevieagacer
 
GBSN - Microbiology (Unit 1)
GBSN - Microbiology (Unit 1)GBSN - Microbiology (Unit 1)
GBSN - Microbiology (Unit 1)Areesha Ahmad
 
GBSN - Microbiology (Unit 3)
GBSN - Microbiology (Unit 3)GBSN - Microbiology (Unit 3)
GBSN - Microbiology (Unit 3)Areesha Ahmad
 
High Class Escorts in Hyderabad ₹7.5k Pick Up & Drop With Cash Payment 969456...
High Class Escorts in Hyderabad ₹7.5k Pick Up & Drop With Cash Payment 969456...High Class Escorts in Hyderabad ₹7.5k Pick Up & Drop With Cash Payment 969456...
High Class Escorts in Hyderabad ₹7.5k Pick Up & Drop With Cash Payment 969456...chandars293
 
chemical bonding Essentials of Physical Chemistry2.pdf
chemical bonding Essentials of Physical Chemistry2.pdfchemical bonding Essentials of Physical Chemistry2.pdf
chemical bonding Essentials of Physical Chemistry2.pdfTukamushabaBismark
 
Biogenic Sulfur Gases as Biosignatures on Temperate Sub-Neptune Waterworlds
Biogenic Sulfur Gases as Biosignatures on Temperate Sub-Neptune WaterworldsBiogenic Sulfur Gases as Biosignatures on Temperate Sub-Neptune Waterworlds
Biogenic Sulfur Gases as Biosignatures on Temperate Sub-Neptune WaterworldsSérgio Sacani
 
Digital Dentistry.Digital Dentistryvv.pptx
Digital Dentistry.Digital Dentistryvv.pptxDigital Dentistry.Digital Dentistryvv.pptx
Digital Dentistry.Digital Dentistryvv.pptxMohamedFarag457087
 
Call Girls Ahmedabad +917728919243 call me Independent Escort Service
Call Girls Ahmedabad +917728919243 call me Independent Escort ServiceCall Girls Ahmedabad +917728919243 call me Independent Escort Service
Call Girls Ahmedabad +917728919243 call me Independent Escort Serviceshivanisharma5244
 

Último (20)

development of diagnostic enzyme assay to detect leuser virus
development of diagnostic enzyme assay to detect leuser virusdevelopment of diagnostic enzyme assay to detect leuser virus
development of diagnostic enzyme assay to detect leuser virus
 
Pests of mustard_Identification_Management_Dr.UPR.pdf
Pests of mustard_Identification_Management_Dr.UPR.pdfPests of mustard_Identification_Management_Dr.UPR.pdf
Pests of mustard_Identification_Management_Dr.UPR.pdf
 
Vip profile Call Girls In Lonavala 9748763073 For Genuine Sex Service At Just...
Vip profile Call Girls In Lonavala 9748763073 For Genuine Sex Service At Just...Vip profile Call Girls In Lonavala 9748763073 For Genuine Sex Service At Just...
Vip profile Call Girls In Lonavala 9748763073 For Genuine Sex Service At Just...
 
Introduction to Viruses
Introduction to VirusesIntroduction to Viruses
Introduction to Viruses
 
SAMASTIPUR CALL GIRL 7857803690 LOW PRICE ESCORT SERVICE
SAMASTIPUR CALL GIRL 7857803690  LOW PRICE  ESCORT SERVICESAMASTIPUR CALL GIRL 7857803690  LOW PRICE  ESCORT SERVICE
SAMASTIPUR CALL GIRL 7857803690 LOW PRICE ESCORT SERVICE
 
Kochi ❤CALL GIRL 84099*07087 ❤CALL GIRLS IN Kochi ESCORT SERVICE❤CALL GIRL
Kochi ❤CALL GIRL 84099*07087 ❤CALL GIRLS IN Kochi ESCORT SERVICE❤CALL GIRLKochi ❤CALL GIRL 84099*07087 ❤CALL GIRLS IN Kochi ESCORT SERVICE❤CALL GIRL
Kochi ❤CALL GIRL 84099*07087 ❤CALL GIRLS IN Kochi ESCORT SERVICE❤CALL GIRL
 
Proteomics: types, protein profiling steps etc.
Proteomics: types, protein profiling steps etc.Proteomics: types, protein profiling steps etc.
Proteomics: types, protein profiling steps etc.
 
COST ESTIMATION FOR A RESEARCH PROJECT.pptx
COST ESTIMATION FOR A RESEARCH PROJECT.pptxCOST ESTIMATION FOR A RESEARCH PROJECT.pptx
COST ESTIMATION FOR A RESEARCH PROJECT.pptx
 
pumpkin fruit fly, water melon fruit fly, cucumber fruit fly
pumpkin fruit fly, water melon fruit fly, cucumber fruit flypumpkin fruit fly, water melon fruit fly, cucumber fruit fly
pumpkin fruit fly, water melon fruit fly, cucumber fruit fly
 
Connaught Place, Delhi Call girls :8448380779 Model Escorts | 100% verified
Connaught Place, Delhi Call girls :8448380779 Model Escorts | 100% verifiedConnaught Place, Delhi Call girls :8448380779 Model Escorts | 100% verified
Connaught Place, Delhi Call girls :8448380779 Model Escorts | 100% verified
 
High Profile 🔝 8250077686 📞 Call Girls Service in GTB Nagar🍑
High Profile 🔝 8250077686 📞 Call Girls Service in GTB Nagar🍑High Profile 🔝 8250077686 📞 Call Girls Service in GTB Nagar🍑
High Profile 🔝 8250077686 📞 Call Girls Service in GTB Nagar🍑
 
Pests of cotton_Sucking_Pests_Dr.UPR.pdf
Pests of cotton_Sucking_Pests_Dr.UPR.pdfPests of cotton_Sucking_Pests_Dr.UPR.pdf
Pests of cotton_Sucking_Pests_Dr.UPR.pdf
 
Module for Grade 9 for Asynchronous/Distance learning
Module for Grade 9 for Asynchronous/Distance learningModule for Grade 9 for Asynchronous/Distance learning
Module for Grade 9 for Asynchronous/Distance learning
 
GBSN - Microbiology (Unit 1)
GBSN - Microbiology (Unit 1)GBSN - Microbiology (Unit 1)
GBSN - Microbiology (Unit 1)
 
GBSN - Microbiology (Unit 3)
GBSN - Microbiology (Unit 3)GBSN - Microbiology (Unit 3)
GBSN - Microbiology (Unit 3)
 
High Class Escorts in Hyderabad ₹7.5k Pick Up & Drop With Cash Payment 969456...
High Class Escorts in Hyderabad ₹7.5k Pick Up & Drop With Cash Payment 969456...High Class Escorts in Hyderabad ₹7.5k Pick Up & Drop With Cash Payment 969456...
High Class Escorts in Hyderabad ₹7.5k Pick Up & Drop With Cash Payment 969456...
 
chemical bonding Essentials of Physical Chemistry2.pdf
chemical bonding Essentials of Physical Chemistry2.pdfchemical bonding Essentials of Physical Chemistry2.pdf
chemical bonding Essentials of Physical Chemistry2.pdf
 
Biogenic Sulfur Gases as Biosignatures on Temperate Sub-Neptune Waterworlds
Biogenic Sulfur Gases as Biosignatures on Temperate Sub-Neptune WaterworldsBiogenic Sulfur Gases as Biosignatures on Temperate Sub-Neptune Waterworlds
Biogenic Sulfur Gases as Biosignatures on Temperate Sub-Neptune Waterworlds
 
Digital Dentistry.Digital Dentistryvv.pptx
Digital Dentistry.Digital Dentistryvv.pptxDigital Dentistry.Digital Dentistryvv.pptx
Digital Dentistry.Digital Dentistryvv.pptx
 
Call Girls Ahmedabad +917728919243 call me Independent Escort Service
Call Girls Ahmedabad +917728919243 call me Independent Escort ServiceCall Girls Ahmedabad +917728919243 call me Independent Escort Service
Call Girls Ahmedabad +917728919243 call me Independent Escort Service
 

Faculty showcase 2013 - Opening up clinical performance

  • 1. Opening up clinical performance variation and financial incentives in Primary Care quality of care Evan (Evangelos) Kontopantelis1 1Institute of Population Health Faculty Research Series, 25 September 2013 Kontopantelis (IPH) Variation and financial incentives 25 September 2013
  • 2. Outline 1 People 2 The scheme... 3 The research journey 4 Summary Kontopantelis (IPH) Variation and financial incentives 25 September 2013
  • 3. Collaborative work! Martin Roland Tim Doran David Reeves Stephen Campbell Bonnie Sibbald Matt Sutton Hugh Gravelle Jose Valderas ...and others... Kontopantelis (IPH) Variation and financial incentives 25 September 2013
  • 4. Improving quality of care a (very) juicy carrot... A pay-for-performance (p4p) program kicked off in April 2004 with the introduction of a new GP contract General practices are rewarded for achieving a set of quality targets for patients with chronic conditions The aim was to increase overall quality of care and to reduce variation in quality between practices The incentive scheme for payment of GPs was named the Quality and Outcomes Framework (QOF) Initial investment estimated at £1.8 bn for 3 years (increasing GP income by up to 25%) QOF is reviewed at least every two years Kontopantelis (IPH) Variation and financial incentives 25 September 2013
  • 5. Quality and Outcomes Framework details for years 1 (2004/5) and 7 (2010/11) Domains and indicators in year 1 (year 7): Clinical care for 10 (19) chronic diseases, with 76 (80) indicators Organisation of care, with 56 (36) indicators Additional services, with 10 (8) indicators Patient experience, with 4 (5) indicators Implemented simultaneously in all practices (a control group was out of the question) Practices are allowed to exclude patients from the indicators and the payment calculations Into the 10th year now (01Mar13/31Apr14); cost for the first 9 years was well above the estimate at £9 bn approximately Kontopantelis (IPH) Variation and financial incentives 25 September 2013
  • 6. Quality and Outcomes Framework what does it mean? If you have Atrial fibrillation, asthma, HT, cancer, CHD, HF, CKD, COPD, dementia, depression, diabetes, epilepsy, SMI, osteoporosis, PAD, stroke, hypothyroidism but also covers LD, obesity, palliative care, sexual health, smoking e.g. for diabetes measure-control BP, chol, glucose immunise for influenza physical exams (retinal screen, foot exam) ...and more... 17 indicators in total Kontopantelis (IPH) Variation and financial incentives 25 September 2013
  • 7. Quality and Outcomes Framework 2005 reaction Drugs cut strokes by a third Doctors get 20% pay rise just for doing their jobsDOCTORS are getting 20 per cent pay rises for doing simple tasks “they should always have done,” it was claimed last night. Health economists, including Government advisers, say that under their new contracts GPs are being paid huge bonuses to meet “easy” targets that do little to improve patients’ lives. Such is the level of concern over the value for taxpayers that ministers are already meeting doctors’ leaders in order to set tougher goals. The move comes just weeks after the Government boasted how most GPs had met the tar- gets for performance-related pay. But Alan Maynard, professor of health economics at York Univer- sity, said yesterday: “It’s quite ridiculous. The Government’s CHOLESTEROL -lowering drugs called statins could pre- vent heart attacks and strokes in a third of patients with diseased arteries, a study shows. Most doctors consider statin treatment only when blood cho- lesterol is above a certain level but research by British and Australian scientists shows many more people with lower cholesterol could also benefit. Statins work by blocking the action of an enzyme that enables the liver to produce cholesterol. Research Council scientist Dr Colin Baigent, who coordinated By Michael Day By Geoff Marsh spent all this money and has given GPs 20 per cent rises just to try and get them to do what they should always have done. “Now they’re being paid extra to look out for people with high blood pressure, which causes heart attacks and strokes, and to monitor and treat them – but they should have been doing that all along. It’s not rocket science.” There have already been two Whitehall meetings after the dis- closure last month that, on aver- age, GP practices achieved 91 per cent of the available perfor- mance-related bonuses under the new contract. After achieving bonuses, aver- age earnings of a practice surged by £75,000 while the salary of the average GP partner rose to £100,000 a year. The first meeting to set tougher targets came with- in a week of the announcement. The second was held last week. One BMA negotiator, Leeds GP Richard Vautrey, said: “We are looking at making amendments, but at present we’re not in the position to say exactly what these are. “We would expect the revised framework to be ready by the end of the year.” Apart from blood pressure, other target areas have been sin- gled out as too modest. Chris Ham, professor of health policy and management at Birmingham University, said: “My view is that, in principle, the new GP contract is a good thing – GPs are being paid on the basis of how well they treat patients and not just accord- ing to how large their list size is. “But the fact so many of them met the targets in the first year suggests they were too easy.” A BMA spokeswoman denied the targets were too easy. “They demonstrate the vast majority of doctors are already providing high-quality care for their patients,” she said. Simon William, director of pol- icy at the Patients’ Association, said, however: “The BMA would trumpet the GPs’ performance. It’s a trade union, it’s there to represent doctors not patients.” A spokesman for the Depart- ment of Health said: “These excellent results show the new contract is giving GPs a real incentive to improve the quality of care.” the research at Oxford Univer- sity, said: “This study shows statin drugs could be beneficial in a much wider range of patients than is currently con- sidered for treatment. “What matters most is doc- tors identify all patients at risk of a heart attack or stroke – largely ignoring their present blood cholesterol level – and then prescribe a statin at a daily dose that reduces their choles- terol substantially. “Lowering the bad (LDL) cho- lesterol … with a statin should reduce the risk of a heart attack or stroke by at least one third.” The study, published online in The Lancet, suggests patients given a statin would also experi- ence greater benefits if doctors aimed to achieve larger reduc- tions in cholesterol levels. The analysis also provides information about the safety of statins. Earlier studies had raised concerns they could be linked with an increased risk of certain cancers or diseases. British Heart Foundation Professor Rory Collins, one of the study authors, said: “This work shows clearly that statins are very safe. There is no good evidence that statins cause can- cer and nor do they increase the risk of other diseases. Although statins can cause muscle pain or weakness, our study shows seri- ous cases are extremely rare.” Study co-author Professor John Simes, of Sydney Univer- sity, said: “The benefits of statin treatment were seen in all pat- ient groups, including women, the elderly, individuals with dia- betes and those with and with- out prior heart attack or stroke.” OPINION 12 DIARY 26 LETTERS 38 TV 39 STARS 43 CROSSWORDS 45 CITY 48 SPORT 52 If you have a story: Ring 0871 520 2982 If you have a photo: Ring 0871 520 7171 or send mobile phone pictures by texting EXPRESS to 07843 500 911 or email to: expresspix@express.co.uk DO YOU HAVE A STORY OR A PHOTO? We asked in our poll on Saturday: Should Blair resign over sending troops to Iraq? Yes:97% No: 3% RESULTS OF PHONE POLL 3 6 5 8 9 3 4 9 4 5 3 6 9 5 7 1 6 1 5 3 9 5 8 7 7 5 1 4 3 5 2 9 8 1 8 6 Fill in all the squares so that each row, each column, and 3x3 square contain all the digits from 1 to 9.SUDOKU 7 8 6 1 9 3 5 2 4 2 1 9 5 7 4 8 6 3 5 3 4 8 2 6 9 7 1 4 9 7 2 1 5 6 3 8 8 2 5 6 3 7 1 4 9 3 6 1 9 4 8 7 5 2 9 7 2 3 5 1 4 8 6 6 4 3 7 8 9 2 1 5 1 5 8 4 6 2 3 9 7 Yesterday’s solution This is the Quick Sudoku for the solver in a hurry. For today’s solution call: 0905 072 0051 For extra clues call: 0905 072 0052 (calls cost 75p per minute from a BT landline) Another Sudoku: PAGE 45 ● The Daily Express Sudoku Book is available from October 3 at £5.99 (p&p included for UK). Don’t miss out, pre-order your copy now! Send cheque or postal order to Express Bookshop, PO Box 200, Falmouth, Cornwall TR11 4WJ or call 0871 434 6091, or you can order on-line at www.expressbookshop.com LOTTO NUMBERS WEDNESDAY LOTTO September 21 2 23 33 35 40 42 25 Estimated jackpot is £2.8m Extra: 2 13 18 25 28 47 Estimated jackpot is £8.7m T-Ball: 5 14 16 18 32 2 DAILY PLAY Saturday 1 7 8 12 21 23 24 SATURDAY LOTTO Sept 24 2 11 27 29 36 44 15 Estimated jackpot is £8.4m Extra: 3 11 16 34 40 45 Jackpot is £9m this week T-Ball: 6 8 20 26 34 5 EUROMILLIONS September 23 1 26 31 34 47 Lucky star numbers: 4 9 Amsterdam . . .c 17 63 Athens . . . . . . .f 25 77 Berlin . . . . . . . .sh 16 61 Cape Town . . . .s 16 61 Corfu . . . . . . . .f 25 77 Dublin . . . . . . .c 18 64 Faro . . . . . . . . .s 24 75 Geneva . . . . . .f 20 68 Gibraltar . . . . . .f 23 73 Guernsey . . . . .s 17 63 Los Angeles . . .f 21 70 Madrid . . . . . . .s 22 72 Malaga . . . . . . .f 24 75 Mallorca . . . . . .s 24 75 Malta . . . . . . . .s 25 77 Miami . . . . . . . .f 31 88 Moscow . . . . . .c 14 57 New York . . . . .c 22 72 Nice . . . . . . . . .s 24 75 Paris . . . . . . . . .c 20 68 Rome . . . . . . . .s 23 73 Stockholm . . . .s 20 68 Sydney . . . . . .r 19 66 Tel Aviv . . . . . . .s 34 93 Tenerife . . . . . .s 28 82 Summary: Showers in places. World yesterday Europe today C F A windy day with rain spreading eastwards across most areas, but the south and east of England will have a fine start. Outlook tomorrow: North West East Anglia Breezy with scattered showers, locally heavy. A fresh south-westerly wind. High 18C (64F). Early rain will clear to leave sunny spells. A risk of showers later. Moderate south-westerly winds. High 20C (68F). Northern Ireland London/South East Sunny intervals and showers. Cool and breezy with a strong south-westerly breeze. High 16C (61F). After a cloudy start with rain in places, it will soon become drier with spells of sunshine. High 21C (70F). Wales South Some sunshine at times, but with scattered showers, frequent in the west. Fresh winds. High 18C (64F). A cloudy start in places, but turning brighter with sunny spells. Afternoon showers. High 20C (68F). Midlands South West Sunny spells, but with a few showers from the west. Moderate south-westerly winds. High 20C (68F). Some sunshine at times, but with occasional showers. Moderate westerly winds. High 19C (66F). North East/Yorks Channel Isles A bright day with sunny spells, but breezy with the chance of a shower A fresh breeze. High 18C (64F). Early rain will soon clear to leave sunny intervals, but with a risk of a shower. High 18C (64F). Scotland Sea Gusty at times with frequent, heavy showers in the west. Drier and brighter further east. High 18C (64F). North Sea: moderate. Irish Sea: moderate. Channel: moderate. Rain 19C/66F Amsterdam Fair 19C/66F Brussels Fair 22C/72F Frankfurt Fair 23C/73F Geneva Fair 22C/72F Paris Fair 25C/77F Rome Warmest: Chivenor 19C (66F). Coldest: Aboyne 2C (36F). Wettest: S’th Uist Range 0.55in. Sunniest: Beccles 5.0hr. BRITAIN EXTREMES: (24 hours to 2pm yesterday) c-cloudy, dr-drizzle, f-fair, fg-fog, g-gales, h-hail, hz-haze, m-mist, r-rain, sh-showers, s-sun, sn-snow, sl-sleet, th-thunder, Around Britain HIGH TIDE: London Bridge: 9.03am, 10.00pm Liverpool: 7.14am, 7.53pm Greenock: 8.31am, 7.42pm Dover: 7.04am, 8.01pm Belfast 0.0 0.13 9 17 Birmingham 2.0 0.00 9 17 Bristol 2.3 0.00 10 19 Cardiff 3.0 0.01 11 20 Edinburgh 2.0 0.04 7 18 Glasgow 0.9 0.94 10 15 Leeds ** ** 9 16 London 3.4 0.00 12 18 Manchester 1.1 0.00 8 17 Newcastle ** 0.00 10 17 Norwich 3.7 0.04 7 16 Oxford 1.5 0.00 7 17 CITIES Sun Rain Temp (hr) (in) (min)(max) Lighting-up times Yesterday Belfast 7.10pm-7.20am Birmingham 6.54pm-7.03am Bristol 6.57pm-7.06am Glasgow 7.03pm-7.14am London 6.47pm-6.56am Manchester 6.55pm-7.05am Newcastle 6.52pm-7.03am MOON rises: –, Sets: 5.14pm SUN rises London: 6.55am, Sets: 6.47pm Manchester rises: 7.03am, Sets: 6.55pm Moon, sun and tides 25 30 30 20 15 13 13 16 18 18 18 19 17 1818 20 20 20 21 Weather today Miami 31C 88F / Moscow 14C 57F All forecasts and maps provided by PA WeatherCentre Daily Express Tuesday September 27 20052 Kontopantelis (IPH) Variation and financial incentives 25 September 2013
  • 8. Quality and Outcomes Framework later reaction Kontopantelis (IPH) Variation and financial incentives 25 September 2013
  • 9. Key questions since QOF was parachuted in Primary Care What were levels of achievement when QOF introduced? Did they change over time? What was happening pre-QOF? Was there an increasing trend? Practice characteristics asssociated with high performance? Size? Gap between practices in affluent and deprived areas? Exception reporting rates and evidence for practice ‘gaming’? What happened to non-incentivised aspects of care? Did the intervention effect vary by population group? What about patient satisfaction? Various computer systems used. Does system choice affect care? Kontopantelis (IPH) Variation and financial incentives 25 September 2013
  • 10. Timeline 1998 2014 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2003 QuIP tp #2 2005 QuIP tp #3 2009 GP Patient Satisfaction Survey 01/04/2004 QOF introduced 1998 - 2007 QuIP 1998 QuIP time point #1 2005 QOF y1* 2008 GPRD (CPRD) access 2007 QuIP tp #4 2013 QOF y9 2004 - 2014 QMAS Kontopantelis (IPH) Variation and financial incentives 25 September 2013
  • 11. Timeline 1998 2014 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2003 QuIP tp #2 2005 QuIP tp #3 2009 GP Patient Satisfaction Survey 01/04/2004 QOF introduced 2005 Where's the sun? 1998 - 2007 QuIP 1998 QuIP time point #1 2005 QOF y1* 2008 GPRD (CPRD) access 2007 QuIP tp #4 2013 QOF y9 2004 - 2014 QMAS Kontopantelis (IPH) Variation and financial incentives 25 September 2013
  • 12. Levels of achievement in the first year (2004-5) All 8000+ English practices Median reported achievement was 83.4% (IQR: 78.2-87.0%) Very high achievement levels Small effects of sociodemographic characteristics Exception reporting not extensive but the strongest predictor A few practices scored high by excluding large numbers of patients The new engl and jour nal of medicine n engl j med 355;4 www.nejm.org july 27, 2006 375 special article Pay-for-Performance Programs in Family Practices in the United Kingdom Tim Doran, M.P.H., Catherine Fullwood, Ph.D., Hugh Gravelle, Ph.D., David Reeves, Ph.D., Evangelos Kontopantelis, Ph.D., Urara Hiroeh, Ph.D., and Martin Roland, D.M. From the National Primary Care Research and Development Centre, University of Manchester, Manchester, United King- dom. Address reprint requests to Dr. Doran at the National Primary Care Re- search and Development Centre, William- son Bldg., University of Manchester, Man- chester M13 9PL, United Kingdom, or at tim.doran@manchester.ac.uk. N Engl J Med 2006;355:375-84. Copyright © 2006 Massachusetts Medical Society. Abstr act Background In 2004, after a series of national initiatives associated with marked improvements in the quality of care, the National Health Service of the United Kingdom introduced a pay-for-performance contract for family practitioners. This contract increases exist- ing income according to performance with respect to 146 quality indicators cover- ing clinical care for 10 chronic diseases, organization of care, and patient experience. Methods We analyzed data extracted automatically from clinical computing systems for 8105 family practices in England in the first year of the pay-for-performance program (April 2004 through March 2005), data from the U.K. Census, and data on charac- teristics of individual family practices. We examined the proportion of patients deemed eligible for a clinical quality indicator for whom the indicator was met (reported achievement) and the proportion of the total number of patients with a medical con- dition for whom a quality indicator was met (population achievement), and we used multiple regression analysis to determine the extent to which practices achieved high scores by classifying patients as ineligible for quality indicators (exception reporting). Results The median reported achievement in the first year of the new contract was 83.4 per- cent (interquartile range, 78.2 to 87.0 percent). Sociodemographic characteristics of the patients (age and socioeconomic features) and practices (size of practice, num- ber of patients per practitioner, age of practitioner, and whether the practitioner was medically educated in the United Kingdom) had moderate but significant effects on performance. Exception reporting by practices was not extensive (median rate, 6 per- cent), but it was the strongest predictor of achievement: a 1 percent increase in the rate of exception reporting was associated with a 0.31 percent increase in reported achievement. Exception reporting was high in a small number of practices: 1 percent of practices excluded more than 15 percent of patients. Conclusions English family practices attained high levels of achievement in the first year of the new pay-for-performance contract. A small number of practices appear to have achieved high scores by excluding large numbers of patients by exception reporting. More research is needed to determine whether these practices are excluding pa- tients for sound clinical reasons or in order to increase income. Kontopantelis (IPH) Variation and financial incentives 25 September 2013
  • 13. Trends of prior achievement and 2004-5 expectations Representative sample of 42 practices Quality of care for CHD, asthma and diabetes improved between 2003 and 2005, continuing the earlier trend Increase in rate of improvement significant only for asthma and diabetes Better recording or care? Practices were preparing in 2003, in anticipation of the scheme launch? Gains from the scheme become questionable, from a cost-effectiveness perspective n engl j med 357;2  www.nejm.o182 center Manchester National Health Service. Data Collection Trained research staff extracted the data to assess the quality of clinical care for the categories of coronary heart disease (15 clinical indicators), asthma (12 clinical indicators), and type 2 dia- betes (21 clinical indicators). Data were collected from both computerized and handwritten medi- tients pract have for up practi for a tients These acros Alt that w in the clinic asthm incen pared were cial in we ex this d clear vided Statis An ov puted and 2 heart comp cators divide that p repre provid 100. W our p for th 90 MeanPractice-QualityScore(%) 80 85 70 60 55 75 65 0 1998 1999 2000 2001 2002 2003 2004 2005 CHD Asthma Diabetes Year AUTHOR: FIGURE: JOB: 4-C H/T RETAKE SIZE ICM CASE EMail Line H/T Combo Revised AUTHOR, PLEASE NOTE: Figure has been redrawn and type has been reset. Please check carefully. REG F Enon 1st 2nd 3rd Campbell 1 of 1 07-12-07 ARTIST: ts 35702 ISSUE: 22p3 Figure 1. Mean Scores for Clinical Quality at the Practice Level for Coronary Heart Disease, Asthma, and Type 2 Diabetes, 1998 to 2005. The quality of care for coronary heart disease (CHD), asthma, and type 2 diabetes was improving between 1998 and 2003, before the introduction of pay for performance. The rate of improvement in quality of care increased significantly for diabetes and asthma between 2003 and 2005, after the in- troduction of pay for performance; the rate for coronary heart disease, which was increasing most rapidly before pay for performance, continued at the same rate after pay for performance was introduced. The New England Journal of Med Downloaded from nejm.org at UNIV OF MANCHESTER JOHN RYLANDS LIB on September Copyright © 2007 Massachusetts Medical Society spe ci a l r ep or t The new engl and jour nal of medicine Quality of Primary Care in England with the Introduction of Pay for Performance Stephen Campbell, Ph.D., David Reeves, Ph.D., Evangelos Kontopantelis, Ph.D., Elizabeth Middleton, M.Sc., Bonnie Sibbald, Ph.D., and Martin Roland, D.M. In 2004, the United Kingdom committed £1.8 bil- lion ($3.2 billion) to a new pay-for-performance contract for family practitioners.1 During the first year, the levels of achievement exceeded those an- ticipated by the government, with an average of 83.4% of the available incentive payments claimed.2 However, the quality of care in English family practices had already begun to improve in response to a wide range of initiatives,3-6 including nation- al standards for the treatment of major chronic diseases and a national system of inspection (Ta- before the pay-for-performance program was in- troduced and at one time point (2005) after its introduction. A validated set of criteria was used to assess quality in the management of three chronic conditions: asthma, coronary heart dis- ease, and type 2 diabetes. Because some clinical indicators — the measures of the quality of clini- cal care — were not rewarded with financial pay- ments in the 2004 pay-for-performance program, the study design also permitted a comparison of trends in the quality of care for indicators forKontopantelis (IPH) Variation and financial incentives 25 September 2013
  • 14. Performance over time and its variation All 8000+ English practices Median overall achievement was 85.1%, 89.3% and 90.8% in first 3y Median achievement increased by 4.4% for quintile of most affluent and by 7.6% for most deprived Gap in median achievement narrowed from 4.0% to 0.8% Financial incentive schemes can contribute to the reduction of inequalities Information about practice and patient characteristics was taken from the 2006 general medical statistics database, which is maintained by the Department of Health. Practices were grouped into quintiles of equal size on the basis of the level of area deprivation in the census super-output area (a standard, stable unit of geography used in the UK for statistical analysis; average population 7200) where they were located, with data from the Index of Deprivation 2004.20 We calculated the odds of practices from each quintile being in the top and bottom performing 5% of practices with respect to achievement and rates of exclusion by logistic regression. We estimated the associations of practice-level characteristics with practice achievement, exclusion of patients, and changes in these outcomes with multiple linear regressions. These analyses controlled for missing indicators, heterogeneity of variance, and clustering of practices, and we made checks on the robustness of the results to model specifications (webappendix). All variables were divided by their standard deviations, thus regression coefficients show the increase in standard deviations of the outcome for one standard deviation increase in predictor variables. All statistical analyses were done with Stata software (version 9). Achievement data for 2004–05, 2005–06, and 2006–07 were available for 8277 general practices in England. Practices were excluded from the study if they had fewer (164 practices), complete exclusion data were not available (172 practices), or if the practice population changed in size by 25% or more (258 practices). Our main results are drawn from 7637 practices, providing care for more than 49 million patients. We undertook subanalyses for excluded practices (webappendix). Role of the funding source There was no funding source for this study. The corresponding author had full access to all the data in the study and had fi nal responsibility for the decision to submit for publication. Results The median overall reported achievement—the propor- tion of patients who were deemed eligible by the prac- tices for whom the targets were achieved—was 85·1% (IQR 79·0–89·1) in year 1, 89·3% (86·0–91·5) in year 2, and 90·8% (88·5–92·6) in year 3. Increases in achievement between years were significant (p<0·0001 in all cases). Although average levels of achievement in- creased over time, variation in achieve ment diminished. In year 1, progressively lower levels of achievement were associated with increased levels of area deprivation (fi gure 1). Median achievement ranged from 86·8% (IQR 82·2–89·6) for quintile 1 (least deprived) to 82·8% Overallreportedachievement(%) Year 1 (2004–05) 0 20 40 60 80 100 Year 2 (2005–06) Year 3 (2006–07) Quality and outcome framework year Quintile 1 Quintile 2 Quintile 3 Quintile 4 Quintile 5 Figure 1: Distribution of scores for overall reported achievement by deprivation quintile for year 1 (2004–05) to year 3 (2006–07) Central line shows median achievement and box shows interquartile range; whiskers represent range of achievement scores. Circles represent statistical outliers— ie, individual practices with achievement scores outside the range: first quartile–(1·5×IQR) to third quartile+(1·5×IQR). most deprived most affluent Articles Effect of financial incentives on inequalities in the delivery of primary clinical care in England: analysis of clinical activity indicators for the quality and outcomes framework Tim Doran, Catherine Fullwood, Evangelos Kontopantelis, David Reeves Summary Background The quality and outcomes framework is a financial incentive scheme that remunerates general practices in the UK for their performance against a set of quality indicators. Incentive schemes can increase inequalities in the delivery of care if practices in affluent areas are more able to respond to the incentives than are those in deprived areas. We examined the relation between socioeconomic inequalities and delivered quality of clinical care in the first 3 years of this scheme. Methods We analysed data extracted automatically from clinical computing systems for 7637 general practices in England, data from the UK census, and data for characteristics of practices and patients from the 2006 general medical statistics database. Practices were grouped into equal-sized quintiles on the basis of area deprivation in their locality. We calculated overall levels of achievement, defined as the proportion of patients who were deemed eligible by the Lancet 2008; 372: 728–36 Published Online August 12, 2008 DOI:10.1016/S0140- 6736(08)61123-X See Comment page 692 National Primary Care Research and Development Centre, University of Manchester, Manchester, UK (T Doran MD, C Fullwood PhD, E Kontopantelis PhD, Kontopantelis (IPH) Variation and financial incentives 25 September 2013
  • 15. Trends of prior achievement and 2006-7 expectations Representative sample of 42 practices By 2007 the rate of improvement had slowed for all three conditions Quality of care for non-incentivised aspects declined for asthma and CHD No significant changes on access to care or on interpersonal aspects of care Continuity of care reduced immediately after the introduction of the scheme QOF accelerated short-term improvements The new engl and jour nal of medicine incentives as compared with those that were not. in the post-introductio pre-introduction period ly (P = 0.06). However, cant when calculated strapping method (P = (P = 0.03), and in abso ity score for aspects of were not linked to ince whereas the quality sco to incentives increased ate effect of pay for p between care that wa linked with incentives subsequently diverged vs. pre-introduction pe duction period vs. intr with the mean score f to incentives declining score for care that wa creasing. Trends in d at any time according linked to incentives. Communication, Wait and Continuity of Ca The percentages of pat within 48 hours, as w the physician-commu significant changes in declined significantly pay for performance ( this lower level (Table Estimated Overall Eff for Performance For outcomes in whic pay for performance a improvement, we used rupted time-series ana of the increase in sco from the trend in th (back-transforming th analysis, with estimat As compared with the ment based on the pre- for-performance schem 22p3 90 Score 85 80 70 65 55 75 60 0 1998 1999 2000 2001 2002 2003 2007200620052004 Coronary heart disease Asthma Diabetes Year B A AUTHOR: FIGURE: JOB: 4-C H/T RETAKE SIZE ICM CASE EMail Line H/T Combo Revised AUTHOR, PLEASE NOTE: Figure has been redrawn and type has been reset. Please check carefully. REG F Enon 1st 2nd 3rd Campbell 1 of 2 xx-xx-09 ARTIST: ts 360xx ISSUE: 100 Score 90 80 60 50 20 70 40 30 0 1998 1999 2000 2001 2002 2003 2007200620052004 Communication with physicians Continuity of care Able to get an appointment within 48 hr (particular doctor) Able to get an appointment within 48 hr (any doctor) Year Figure 1. Mean Scores for the Quality of Care at the Practice Level, 1998–2007. Panel A shows scores for the quality of care provided for coronary heart disease, asthma, and diabetes. Quality scores range from 0% (no quality indicator was met for any patient) to 100% (all quality indicators were met for all patients). Panel B shows scores for patients’ perceptions of commu- nication with physicians, access to care, and continuity of care. Communi- cation was assessed by asking seven questions, with the answers scored on a six-point scale ranging from “very poor” to “excellent”; continuity of care was assessed with the use of the same six-point scale and a single question: “How often do you see your usual doctor?” Access to care was scored as the percentage of patients who reported that they were able to get an ap- pointment within 48 hours. All scores were rescaled to range from 0 to 100. special article The new engl and jour nal of medicine Effects of Pay for Performance on the Quality of Primary Care in England Stephen M. Campbell, Ph.D., David Reeves, Ph.D., Evangelos Kontopantelis, Ph.D., Bonnie Sibbald, Ph.D., and Martin Roland, D.M. From the National Primary Care Research and Development Centre, University of Abstr act Background A pay-for-performance scheme based on meeting targets for the quality of clinical care was introduced to family practice in England in 2004. Kontopantelis (IPH) Variation and financial incentives 25 September 2013
  • 16. Does the size of the practice matter? All 8000+ English practices In y1 smallest practices had the lowest median reported achievement rates Performance improved over time; smallest practices improved at the fastest rate Caught up by y3 but displayed more variation in performance Small practices represented among best and worst QOF reduced variation in performance and differences between large and small practices e339 proportions over time. Reported achievement The median overall reported achievement, the proportion of patients deemed appropriate by the practice for whom the targets were achieved, was 85.2% in year 1, 89.3% in year 2, and 90.9% in year 3. Increases in achievement between years were statistically significant (P<0.005 in all cases). Median reported achievement in year 1 varied with patients, year 1 (2004–2005) to year 3 (2006–2007). 100 80 60 40 20 0 2004/2005 2005/2006 2006/2007 QOF year list size 1000–1999 2000–2999 3000–3999 4000–5999 6000–7999 8000–9999 10000–11999 12000 or more Overallreportedachievement Figure 2. Distribution of practice scores for overall reported achievement by number of patients, year 1 (2004–2005) to year 3 (2006–2007). Central white line shows median scores and box shows interquartile range (IQR); whiskers represent range of scores. Circles represent statistical outliers — that is, individual practices with points scores outside the range: first quartile — (1.5 × IQR) + (1.5 × IQR). ABSTRACT Background Small general practices are often perceived to provide worse care than larger practices. Aim To describe the comparative performance of small INTRODUCTION Small general practices in the UK, particularly those that are single handed, are often accused of providing poor-quality care. The 2000 NHS Plan cited a need to ‘confirm that single-handed (solo) practices are offering high standards’.1 The Shipman Inquiry identified advantages and disadvantages T Doran, S Campbell, C Fullwood, et al Performance of small general practices under the UK’s Quality and Outcomes Framework Tim Doran, Stephen Campbell, Catherine Fullwood, Evangelos Kontopantelis and Martin RolandBJGP 2010 Kontopantelis (IPH) Variation and financial incentives 25 September 2013
  • 17. Changes in patient experiences 42 practices, random samples of chronic condition and all patients No changes in 2003-7 quality of care for communication, nursing care, coordination & overall satisfaction Aspects of access improved for chronic disease patients only Both samples seeing their usual GP less & less satisfied in continuity Related to incentives to provide rapid appointments ANNALS OF FAMILY MEDICINE ✦ WWW.ANNFAMMED.ORG ✦ VOL. 8, NO. 6 ✦ NOVEMBER/DECEMBER 2010 502 of-access items (P >.05), including ability to see a particular physician or any physician within 48 hours. Patients Randomly Sampled From Registered Lists Results for patients randomly sampled from practice lists matched those for patients with chronic illness in all aspects except the speed-of-access items: no signifi- cant changes over time were observed in any of these items. The only significant changes from 2003 to 2007 were in regard to continuity of care, with a reduction in how often patients reported being able to see their Table 2. Response Rates for Patient Surveys Patient Group 2003 % (n) 2005 % (n) 2007 % (n) Chronic illness samples 55 (1,092) 52 (1,040) 50 (922) Random samples of registered patients 47 (3,873) 45 (3,601) 37 (3,104) Table 3. Summary of Practice Mean GPAQ Scale and Individual Item Scores 2003, 2005, and 2007, for Cross-Sectional Samples of Patients With Chronic Illness and Random Samples of Adult Patients GPAQ Scale and Item Samples of Patients With Chronic Illness Mean (SD)a Samples of Randomly Selected Patients Mean (SD)a 2003 2005 2007 2003 2005 2007 Communication scale 74.5 (10.1) 74.5 (9.3) 76.0 (8.5) 69.5 (10.0) 68.4 (9.4) 69.9 (8.9) Coordination scale 72.1 (7.4) 71.0 (5.8) 73.0 (5.9) 67.0 (5.8) 68.6 (5.1) 68.3 (6.1) Nursing care scale 76.0 (6.1) 76.1 (6.0) 75.3 (8.1) 73.9 (6.2) 73.4 (5.3) 72.9 (7.1) Overall satisfaction scale 81.6 (8.0) 80.6 (8.6) 81.3 (7.7) 75.2 (9.2) 74.7 (10.6) 75.6 (7.9) Item: In general, how often do you see your usual doctor (continuity of care)? 77.2 (8.0) 74.9 (9.4) 70.4 (9.6) 68.2 (13.1) 62.8 (13.5) 62.5 (11.6) Item: Rating of how often patients get to see their usual doctor (rating of continuity of care) 71.5 (9.8) 69.1 (9.9) 67.4 (11.5) 64.6 (13.1) 61.0 (12.2) 61.2 (10.4) Item: Do you get an appointment with a particu- lar doctor within 48 hours? 36.9 (29.5) 38.7 (26.3) 37.0 (22.6) 33.4 (26.2) 35.9 (25.1) 32.3 (21.0) Item: Rating of how quickly an appointment can be made with a particular doctor in the practice 57.3 (17.7) 58.0 (14.1) 56.6 (15.6) 50.0 (18.6) 52.2 (16.0) 53.0 (13.6) Item: Do you get an appointment with any doc- tor within 48 hours? 64.5 (23.9) 68.0 (22.6) 67.2 (19.9) 61.5 (24.2) 63.4 (21.0) 63.8 (22.4) Item: Rating of how quickly an appointment can be made with any doctor in the practice 65.2 (15.2) 64.5 (13.8) 65.5 (14.5) 59.2 (17.2) 61.2 (14.2) 62.4 (13.1) Item: If you need an urgent appointment can you get one on the same day? 81.8 (17.7) 81.2 (15.5) 82.2 (16.8) 79.6 (17.1) 78.2 (17.5) 79.4 (18.8) GPAQ=General Practice Assessment Questionnaire. Note: See the Appendix for a description of how the scales were scored. a Figures relate to raw practice-level scores (mean and standard deviation of practice means). 13/09/2013 Changes in Patient Experiences of PrimaryCare During Health Service Reforms + The Annals of Family Medicine www.annfammed.org doi: 10.1370/afm.1145 Ann Fam Med November 1, 2010 vol. 8 no. 6 499-506 Changes in Patient Experiences of Primary Care During Health Service Reforms in England Between 2003 and 2007 Stephen M. Campbell, PhD1, Evangelos Kontopantelis, PhD1, David Reeves, PhD1, Jose M. Valderas, PhD1, Ella Gaehl, MPhil1, Nicola Small, MPhil1 and Martin O. Roland, DM2 Author Affiliations CORRESPONDING AUTHOR: Stephen Campbell, PhD, National Primary Care Research and Development Centre, University of Manchester, Williamson Bldg, Kontopantelis (IPH) Variation and financial incentives 25 September 2013
  • 18. Patient satisfaction 2007-8 GP Access Survey, all English practices Young, Asian, working FT, with long commuting times: lowest levels of satisfaction and experience of access Ability to take time off to visit GP eliminated the disadvantage in access Patients in small practices more positive for all aspects of access; except opening hours Positive access to care associated with higher QOF scores and slightly lower rates of emergency admission 0 20 40 60 80 100 %ofpositiveresponses <1 1−2 2−3 3−4 4−6 6−88−1010−12>=12 Phone access 0 20 40 60 80 100 %ofpositiveresponses <1 1−2 2−3 3−4 4−6 6−88−1010−12>=12 Appointment within 2 days 0 20 40 60 80 100 %ofpositiveresponses <1 1−2 2−3 3−4 4−6 6−88−1010−12>=12 Advance appointment (>2 days) 0 20 40 60 80 100 %ofpositiveresponses <1 1−2 2−3 3−4 4−6 6−88−1010−12>=12 Appointment with a particular GP Practice size in 1,000s of patients by practice list size Satisfaction & positive experience RESEARCH ARTICLE Open Access Patient experience of access to primary care: identification of predictors in a national patient survey Evangelos Kontopantelis1* , Martin Roland2 , David Reeves1 Abstract Background: The 2007/8 GP Access Survey in England measured experience with five dimensions of access: getting through on the phone to a practice, getting an early appointment, getting an advance appointment, Kontopantelis et al. BMC Family Practice 2010, 11:61 http://www.biomedcentral.com/1471-2296/11/61 Kontopantelis (IPH) Variation and financial incentives 25 September 2013
  • 19. Advising NICE on removing indicators All English practices, 2004/5 to 2009/10 Indicators should be removed on statistical criteria and the economics of incentives Replaced with other indicators to drive improvement in other areas It is unknown what will happen to the withdrawn indicators BMJ | 24 APRIL 2010 | VOLUME 340 899 ANALYSIS Increasing numbers of countries are using indi- cators to evaluate the quality of clinical care, with some linking payment to achievement.1 For performance frameworks to remain effective the indicators need to be regularly reviewed. The frameworks cannot cover all clinical areas, and achievement on chosen indicators will even- tually reach a ceiling beyond which further improvement is not feasible.2 3 However, there has been little work on how to select indictors for replacement. The Department of Health decided in 2008 that it would regularly replace indicators in the national primary care pay for performance scheme, the Quality and Outcomes Framework,4 making a rigorous approach to removal a prior- ity. We draw on our previous work on pay for performance5 6 and our current work advising the National Institute for Health and Clinical Excellence (NICE) on the Quality and Outcomes Framework to suggest what should be consid- ered when planning to remove indicators from a clinical performance framework. First UK decisions The Quality and Outcomes Framework cur- rently includes 134 indicators for which gen- eral practices can earn up to a total of 1000 points. Negotiations between the Department of Health and the BMA’s General Practitioners Committee last autumn led to an agreement to remove eight clinical indicators worth 28 points in April 2011 (table 1). The eight indicators are all process measures and reward actions such as taking blood pressure or taking blood to measure cholesterol, glucose, or creatinine concentra- tions for people with relevant chronic diseases. The framework rewards the action itself rather than a clinically informed response to results or intermediate outcomes such as better control of blood pressure or cholesterol levels. It is there- fore not surprising that achievement of these process indicators is high (median >95% and interquartile range <4.5%) with little change in rates or variation across practices since 2005-6, the second year of the Quality and Outcomes Framework. In many schemes, including the Quality and Outcomes Framework, providers can “except” certain patients from inclusion in the denomi- nator figures for an indicator on grounds such as extreme frailty or contraindications to a specified drug. Exception reporting rates are also low for these eight indicators (median <5% and inter- quartile range <3%). How to identify when a performance indicator has run its course In April 2011 eight clinical indicators will be removed from the UK Quality and Outcomes Framework. David Reeves and colleagues explain why they were chosen and suggest a rationale for future decisions National achievement and exception rates for indicators that are to be removed from the Quality and Outcomes Frameworkin 20117 Indicator (measurement of ) Condition Median (interquartile range) achievement (%) Median (interquartile range) rate of exceptions (%) Paired indicator*2005-6 2006-7 2007-8 2005-6 2006-7 2007-8 Bloodpressure Coronaryheartdisease 98.2 (96.7-99.3) 98.5 (97.2-99.5) 98.4(97.1-99.4) 0.8 (0-1.8) 0.8 (0-1.7) 0.7 (0-1.6) Yes Haemoglobin A1c Diabetes 97.4 (95.1-98.8) 97.8 (95.9-99.0) 97.7 (96.0-98.9) 2.7 (1.4-4.4) 2.5 (1.3-4.2) 2.4 (1.2-3.9) Yes Bloodpressure Diabetes 98.8 (97.6-99.7) 99.0 (98.0-100) 98.9 (97.9-99.6) 1.1 (0.3-2.2) 1.0 (0.3-2.1) 1.0 (0.3-2.1) Yes Serum creatinine Diabetes 96.7 (94.1-98.3) 97.4 (95.3-98.7) 97.4 (95.6-98.7) 1.9 (0.9-3.4) 1.7 (0.8-3.2) 1.6 (0.7-3.1) No Totalcholesterol Diabetes 96.4 (93.8-98.1) 96.9 (94.8-98.3) 96.8 (94.8-98.2) 2.2 (1.1-3.9) 2.1 (1.0-3.8) 2.0 (0.9-3.6) Yes Serum creatinine andthyroid stimulating hormone Mentalhealth (lithium) 100 (100-100) 100 (100-100) 100 (100-100) 0 (0-0) 0 (0-0) 0 (0-0) No Bloodpressure Stroke 97.4 (95.1-100) 97.7 (95.8-100) 97.6 (95.8-99.5) 1.3 (0-3.3) 1.2 (0-2.9) 1.1 (0-2.7) Yes Thyroidfunction Hypothyroidism 96.8 (94.5-98.7) 96.7 (94.5-98.5) 96.5 (94.3-98.3) 0 (0-0.9) 0 (0-0.9) 0 (0-0.8) No *Paired indicators relate to control of the relevant measure—for example, the indicator that focuses on recording blood pressure in patients with coronary heart disease, is paired with another indicator that rewards on the basis of the proportion of patients whose last blood pressure reading was ≤150/90 mm Hg. BMJ | 24 april 2010 | Volume 340 899 tually reach a ceiling beyond which further improvement is not feasible.2 3 However, there has been little work on how to select indictors for replacement. The Department of Health decided in 2008 that it would regularly replace indicators in the national primary care pay for performance scheme, the Quality and Outcomes Framework,4 making a rigorous approach to removal a prior- ity. We draw on our previous work on pay for performance5 6 and our current work advising the National Institute for Health and Clinical Excellence (NICE) on the Quality and Outcomes Framework to suggest what should be consid- ered when planning to remove indicators from a clinical performance framework. First UK decisions The Quality and Outcomes Framework cur- rently includes 134 indicators for which gen- eral practices can earn up to a total of 1000 points. Negotiations between the Department of Health and the BMA’s General Practitioners ­Committee last autumn led to an agreement to remove eight clinical indicators worth 28 points in April 2011 (table 1). The eight indicators are all process measures and reward actions such as taking blood pressure or taking blood to measure ­cholesterol, glucose, or creatinine concentra- tions for people with relevant chronic diseases. The framework rewards the action itself rather than a clinically informed response to results or intermediate outcomes such as better control of blood pressure or cholesterol levels. It is there- fore not surprising that achievement of these process indicators is high (median >95% and interquartile range <4.5%) with little change in rates or variation across practices since 2005-6, the second year of the Quality and Outcomes Framework. In many schemes, including the Quality and Outcomes Framework, providers can “except” certain patients from inclusion in the denomi- nator figures for an indicator on grounds such as extreme frailty or contraindications to a specified drug. Exception reporting rates are also low for these eight indicators (median <5% and inter- quartile range <3%). National achievement and exception rates for indicators that are to be removed from the Quality and Outcomes Frameworkin 20117 Indicator (measurement of ) Condition Median (interquartile range) achievement (%) Median (interquartile range) rate of exceptions (%) Paired indicator*2005-6 2006-7 2007-8 2005-6 2006-7 2007-8 Bloodpressure Coronaryheartdisease 98.2 (96.7-99.3) 98.5 (97.2-99.5) 98.4(97.1-99.4) 0.8 (0-1.8) 0.8 (0-1.7) 0.7 (0-1.6) Yes Haemoglobin A1c Diabetes 97.4 (95.1-98.8) 97.8 (95.9-99.0) 97.7 (96.0-98.9) 2.7 (1.4-4.4) 2.5 (1.3-4.2) 2.4 (1.2-3.9) Yes Bloodpressure Diabetes 98.8 (97.6-99.7) 99.0 (98.0-100) 98.9 (97.9-99.6) 1.1 (0.3-2.2) 1.0 (0.3-2.1) 1.0 (0.3-2.1) Yes Serum creatinine Diabetes 96.7 (94.1-98.3) 97.4 (95.3-98.7) 97.4 (95.6-98.7) 1.9 (0.9-3.4) 1.7 (0.8-3.2) 1.6 (0.7-3.1) No Totalcholesterol Diabetes 96.4 (93.8-98.1) 96.9 (94.8-98.3) 96.8 (94.8-98.2) 2.2 (1.1-3.9) 2.1 (1.0-3.8) 2.0 (0.9-3.6) Yes Serum creatinine andthyroid stimulating hormone Mentalhealth (lithium) 100 (100-100) 100 (100-100) 100 (100-100) 0 (0-0) 0 (0-0) 0 (0-0) No Bloodpressure Stroke 97.4 (95.1-100) 97.7 (95.8-100) 97.6 (95.8-99.5) 1.3 (0-3.3) 1.2 (0-2.9) 1.1 (0-2.7) Yes Thyroidfunction Hypothyroidism 96.8 (94.5-98.7) 96.7 (94.5-98.5) 96.5 (94.3-98.3) 0 (0-0.9) 0 (0-0.9) 0 (0-0.8) No *Paired indicators relate to control of the relevant measure—for example, the indicator that focuses on recording blood pressure in patients with coronary heart disease, is paired with another indicator that rewards on the basis of the proportion of patients whose last blood pressure reading was ≤150/90 mm Hg. Kontopantelis (IPH) Variation and financial incentives 25 September 2013
  • 20. Non-incentivised aspects of care Sample of 148 representative practices from the CPRD Achievement rates improved for most indicators in the pre-incentive period Significant initial gains in incentivised indicators but no gains in later years No overall effect on the rate of improvement for non incentivised indicators in 2004-5 But by 2006-7 achievement rates significantly below those predicted by pre-incentive trends Figure Mean achievement rate of 148 general practices for qua grouped by activity and whether they were incentivised mean rate is the mean of the adjusted means for the in Effect of financial incentives on incentivised and non-incentivised clinical activities: longitudinal analysis of data from the UK Quality and Outcomes Framework Tim Doran clinical research fellow1 , Evangelos Kontopantelis research associate1 , Jose M Valderas clinical lecturer 2 , Stephen Campbell senior research fellow 1 , Martin Roland professor of health services research3 , Chris Salisbury professor of primary healthcare4 , David Reeves senior research fellow 1 1 National Primary Care Research and Development Centre, University of Manchester, Manchester M13 9PL, UK; 2 NIHR School for Primary Care Research, Department of Primary Health Care, University of Oxford, Oxford OX3 7LF; 3 General Practice and Primary Care Research Unit, University of Cambridge, Cambridge CB2 0SR; 4 Academic Unit of Primary Health Care, University of Bristol, Bristol BS8 2AA Abstract Objective To investigate whether the incentive scheme for UK general practitioners led them to neglect activities not included in the scheme. Design Longitudinal analysis of achievement rates for 42 activities (23 included in incentive scheme, 19 not included) selected from 428 identified indicators of quality of care. Setting 148 general practices in England (653 500 patients). Main outcome measures Achievement rates projected from trends in the pre-incentive period (2000-1 to 2002-3) and actual rates in the first Introduction Over the past two decades funders and policy makers worldwide have experimented with initiatives to change physicians’ behaviour and improve the quality and efficiency of medical care.1 Success has been mixed, and attention has recently turned to payment mechanism reform, in particular offering direct financial incentives to providers for delivering high quality care.2 In 2004 in the UK the Quality and Outcomes Framework (QOF) was introduced—a mechanism intended to improve BMJ 2011;342:d3590 doi: 10.1136/bmj.d3590 Page 1 of 12 Research RESEARCH Kontopantelis (IPH) Variation and financial incentives 25 September 2013
  • 21. Reasons for exception reporting patients All English practices in 2008-9 Median exception rate was 2.7% (IQR 1.9-3.9%) overall and 0.44% (0.14-1.1%) for informed dissent Common reasons logistical (40.6%), clinical contraindication (18.7%), patient informed dissent (30.1%) Higher rates associated with: larger practices, higher deprivation, failure to secure maximum remuneration in previous year Cost of the provision relatively low at £0.58 per patient (£31m) Relatively few patients excluded for informed dissent, suggesting that the incentivised activities were broadly acceptable to patientsFigures Fig 1 Proportion of patients exception reported by indicator and reason, 2008-9. For 37 indicators for which reasons for exception reporting were ascribable (see table 1). Indicators ordered by type of activity (measurement or outcome) and by rate of exception reporting attributable to informed dissent BMJ 2012;344:e2405 doi: 10.1136/bmj.e2405 (Published 17 April 2012) Page 11 of 11 RESEARCH Exempting dissenting patients from pay for performance schemes: retrospective analysis of exception reporting in the UK Quality and Outcomes Framework OPEN ACCESS Tim Doran clinical research fellow 1 , Evangelos Kontopantelis research fellow 1 , Catherine Fullwood research associate 2 , Helen Lester professor of primary care 3 , Jose M Valderas clinical lecturer 4 , Stephen Campbell senior research fellow 1 1 Health Sciences Research Group-Primary Care, University of Manchester, Manchester M13 9PL, UK; 2 Manchester Academic Health Science Centre, Central Manchester University Hospitals NHS Foundation Trust, University of Manchester; 3 School of Health and Population Sciences, University of Birmingham, Birmingham, UK; 4 NIHR School for Primary Care Research, Health Services and Policy Research Group, Department of Primary Care Health Sciences, University of Oxford, Oxford, UK Abstract Objective To examine the reasons why practices exempt patients from the UK Quality and Outcomes Framework pay for performance scheme (exception reporting) and to identify the characteristics of general Conclusions The provision to exception report enables practices to exempt dissenting patients without being financially penalised. Relatively few patients were excluded for informed dissent, however, suggesting that the incentivised activities were broadly acceptable to patients. BMJ 2012;344:e2405 doi: 10.1136/bmj.e2405 (Published 17 April 2012) Page 1 of 11 Research RESEARCH Kontopantelis (IPH) Variation and financial incentives 25 September 2013
  • 22. Changes to the incentives All English practices, 2004-5 to 2009-10 Four influenza immunisation indicators for CHD, COPD, diabetes and stroke Upper threshold increased by 5% only for CHD in 2006-7 The increase led to increase in the % of immunised CHD patients by 0.41% but also to exception reporting by 0.26% Making quality targets more demanding can lead to improvement in quality of care but can also have other consequences Minimum threshold y1/2 Mminimum threshold y3/5 Maximum threshold y1/2 Maximum threshold y3/5 02004006008001000 Numberofpractices 0 20 40 60 80 100 Percentage of patients 08/09 07/08 06/07 05/06 04/05 CHD 12 Reported achievement Family Doctor Responses to Changes in Incentives for Influenza Immunization under the U.K. Quality and Outcomes Framework Pay-for-Performance Scheme Evangelos Kontopantelis, Tim Doran, Hugh Gravelle, Rosalind Goudie, Luigi Siciliani, and Matt Sutton Objective. To analyze the effect of setting higher targets, in a primary care pay-for- performance scheme, on rates of influenza immunization and exception reporting. © Health Research and Educational Trust DOI: 10.1111/j.1475-6773.2011.01362.x RESEARCH ARTICLE Health Services Research Health Services Research, 2012 Kontopantelis (IPH) Variation and financial incentives 25 September 2013
  • 23. Patient level diabetes care Sample of 148 representative practices from the CPRD In 2004-5 quality improved over-and-above this pre-incentive trend by 14.2% By 2006-7 the improvement above trend was smaller at 7.3 Levels of care varied significantly for sex, age, years of previous care, number of co-morbid conditions Recorded quality of primary care for patients with diabetes in England before and after the introduction of a financial incentive scheme: a longitudinal observational study Evangelos Kontopantelis,1 David Reeves,1 Jose M Valderas,2,3 Stephen Campbell,1 Tim Doran1 ▸ An additional data is published online only. To view this file please visit the journal online (http://bmjqs.bmj.com) 1 Health Sciences Primary Care Research Group, University of ABSTRACT Background The UK’s Quality and Outcomes Framework (QOF) was introduced in 2004/5, linking remuneration for general practices to recorded quality of care for chronic conditions, years were more modest. Variation in care between population groups diminished under the incentives, but remained substantial in some cases. ORIGINAL RESEARCH group.bmj.comon September 13, 2013 - Published byqualitysafety.bmj.comDownloaded from Recorded QOF care did not vary significantly by area deprivation before or after the introduction of the incentivisation scheme. However, the effect of the inter- vention did vary with area deprivation: patients attend- ing practices from the most deprived quartile appear to have gained less from the intervention compared with patients in the most affluent quartile of practices, by 4.9% in 2004/5 and 3.8% in 2006/7. There was significant variation in recorded QOF care by practice diabetes prevalence rates, but the differences Figure 2 Aggregate patient level Quality and Outcomes Framework care and predictions based on the pre-incentivisation trend. on Sequalitysafety.bmj.comDownloaded from 2000/1 2001/2 2002/3 2003/4 2004/5 2005/6 2006/7 new diagno 44.7 50.4 56.5 65.3 73.4 74.2 74.3 1-4 years 48.4 53.9 59.4 71.1 80.9 83 83.2 5-9 years 46.4 51.9 56.8 69.1 78.7 81.4 81.8 10+ years 45.4 50 55.1 66.7 77.6 79.3 80.4 2000/1 2001/2 2002/3 2003/4 2004/5 2005/6 2006/7 new diagnoses 44.7 50.4 56.5 65.3 73.4 74.2 74.3 1-4 years 48.4 53.9 59.4 71.1 80.9 83 83.2 5-9 years 46.4 51.9 56.8 69.1 78.7 81.4 81.8 10+ years 45.4 50 55.1 66.7 77.6 79.3 80.4 40 45 50 55 60 65 70 75 80 85 90 aggregaterecordedQOFcarescore Kontopantelis (IPH) Variation and financial incentives 25 September 2013
  • 24. Clinical computer systems All English practices, 2007-8 to 2010-11 Seven clinical computer systems consistently active collectively holding ≈ 99% of the market share System choice strongest predictor of performance on 62 stable care indicators Differences greatest for intermediate outcome indicators Particular system characteristics facilitate higher quality of care, better data recording or both? North East North West London West Midlands Yorkshire & the Humber South West East Midlands East of England South Central South East Coast (85.4,85.7] (85.1,85.4] (84.8,85.1] (84.5,84.8] (84.2,84.5] [83.9,84.2] LV Vision 3 ProdSysOneX PCS Synergy Practice Manager Premiere NOTE: Chart size proportional to number of practices in area Average practice scores by Strategic Health Authority, 2010−11 Overall population achievement (62 indicators) and GP systems products Relationship between quality of care and choice of clinical computing system: retrospective analysis of family practice performance under the UK’s quality and outcomes framework Evangelos Kontopantelis,1,2 Iain Buchan,3 David Reeves,1,2 Kath Checkland,1 Tim Doran4 To cite: Kontopantelis E, Buchan I, Reeves D, et al. Relationship between quality of care and choice of clinical computing system: retrospective analysis of family practice performance under the UK’s quality and outcomes framework. BMJ ABSTRACT Objectives: To investigate the relationship between performance on the UK Quality and Outcomes Framework pay-for-performance scheme and choice of clinical computer system. Design: Retrospective longitudinal study. Setting: Data for 2007–2008 to 2010–2011, extracted from the clinical computer systems of general practices ARTICLE SUMMARY Article focus ▪ Practice and patient-level characteristics are known predictors of quality of care, as measured by the Quality and Outcomes Framework (QOF) indicators. ▪ Various general practitioner (GP) clinical com- Open Access Research group.bmj.comon September 13, 2013 - Published bybmjopen.bmj.comDownloaded from Kontopantelis (IPH) Variation and financial incentives 25 September 2013
  • 25. Getting there... Very high levels of initial achievent leading to overpayment Still confusion about whether the aim is to reward high quality of care or to drive improvement It appears that the same levels of care would have been met eventually; QOF just took us there quicker 050010001500 Numberofpractices 0 20 40 60 80 100 Percentage of patients 08/09 07/08 06/07 05/06 04/05 Overall, 48+2 (smoking) indicators Reported achievement Kontopantelis (IPH) Variation and financial incentives 25 September 2013
  • 26. Getting there... Reduced inequalities but negatively affected continuity and aspects of non incentivised care QOF led to bigger, better organised practices but patients do not seem to like that Exception reporting a cheap provision to ensure no patient discrimination Small changes in the scheme details can have big effects on quality of care The intervention effect varied by patient groups Strongest predictor of achievement was clinical system Kontopantelis (IPH) Variation and financial incentives 25 September 2013
  • 27. What’s to be done with it? good on paper but massive cost Limit incentives to intermediate outcome indicators only? Remove the upper thresholds for indicators, thereby reducing the cost and driving improvement? Re-negotiate the payment platform for the same reason? Bigger range of indicators and only a random set assessed each year? Drop the whole scheme and re-invest in other ventures? Kontopantelis (IPH) Variation and financial incentives 25 September 2013
  • 28. More questions What happens when the incentive for an indicator is removed? What is the effect of the incentivisation on harder outcomes? mortality complications (e.g. for diabetes) What really happens with exceptions and is there any gaming? Kontopantelis (IPH) Variation and financial incentives 25 September 2013
  • 29. Thank you for listening! Comments and questions: e.kontopantelis@manchester.ac.uk Kontopantelis (IPH) Variation and financial incentives 25 September 2013